Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Osteoporosis

  Free Subscription


Articles published in Osteoporos Int

Retrieve available abstracts of 701 articles:
HTML format
Text format



Single Articles


    August 2018
  1. HAUGER AV, Bergland A, Holvik K, Stahle A, et al
    Osteoporosis and osteopenia in the distal forearm predict all-cause mortality independent of grip strength: 22-year follow-up in the population-based Tromso Study.
    Osteoporos Int. 2018 Aug 9. pii: 10.1007/s00198-018-4653.
    PubMed     Text format     Abstract available


  2. MAZZUCCHELLI R, Crespi Villarias N, Perez Fernandez E, Durban Reguera ML, et al
    Short-term association between outdoor air pollution and osteoporotic hip fracture.
    Osteoporos Int. 2018 Aug 9. pii: 10.1007/s00198-018-4605.
    PubMed     Text format     Abstract available


  3. XU Y, Wu Q
    Decreasing trend of bone mineral density in US multiethnic population: analysis of continuous NHANES 2005-2014.
    Osteoporos Int. 2018 Aug 8. pii: 10.1007/s00198-018-4648.
    PubMed     Text format     Abstract available


  4. GIANGREGORIO LM, Gibbs JC, Templeton JA, Adachi JD, et al
    Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fracture.
    Osteoporos Int. 2018 Aug 8. pii: 10.1007/s00198-018-4652.
    PubMed     Text format     Abstract available


  5. ZHANG YS, Weng WY, Xie BC, Meng Y, et al
    Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials.
    Osteoporos Int. 2018 Aug 6. pii: 10.1007/s00198-018-4649.
    PubMed     Text format     Abstract available


  6. GAMBOA A, Duaso E, Marimon P, Sandiumenge M, et al
    Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit.
    Osteoporos Int. 2018 Aug 3. pii: 10.1007/s00198-018-4622.
    PubMed     Text format     Abstract available


    July 2018
  7. FERRARI SL, Abrahamsen B, Napoli N, Akesson K, et al
    Diagnosis and management of bone fragility in diabetes: an emerging challenge.
    Osteoporos Int. 2018 Jul 31. pii: 10.1007/s00198-018-4650.
    PubMed     Text format     Abstract available


  8. MUNHOZ DA ROCHA LEMOS COSTA T, Costa FM, Hoffman Jonasson T, Aguiar Moreira C, et al
    Bone mineral density and vertebral fractures and their relationship with pulmonary dysfunction in patients with chronic obstructive pulmonary disease.
    Osteoporos Int. 2018 Jul 25. pii: 10.1007/s00198-018-4643.
    PubMed     Text format     Abstract available


  9. HIDAYAT K, Du X, Shi BM
    Sex hormone-binding globulin and risk of fracture in older adults: systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2018 Jul 24. pii: 10.1007/s00198-018-4600.
    PubMed     Text format     Abstract available


  10. KYVERNITAKIS I, Kostev K, Hadji P
    The tamoxifen paradox-influence of adjuvant tamoxifen on fracture risk in pre- and postmenopausal women with breast cancer.
    Osteoporos Int. 2018 Jul 21. pii: 10.1007/s00198-018-4642.
    PubMed     Text format     Abstract available


  11. SONG LJ, Wang LL, Ning L, Fan SW, et al
    A modification and validation of quantitative morphometry classification system for osteoporotic vertebral compressive fractures in mainland Chinese.
    Osteoporos Int. 2018 Jul 20. pii: 10.1007/s00198-018-4641.
    PubMed     Text format     Abstract available


  12. KANAZAWA I, Notsu M, Miyake H, Tanaka K, et al
    Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus.
    Osteoporos Int. 2018 Jul 20. pii: 10.1007/s00198-018-4638.
    PubMed     Text format     Abstract available


  13. NORDKLINT AK, Almdal TP, Vestergaard P, Lundby-Christensen L, et al
    The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial.
    Osteoporos Int. 2018 Jul 19. pii: 10.1007/s00198-018-4637.
    PubMed     Text format     Abstract available


  14. LIU J, Guo H, Rai P, Pinto L, et al
    Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis.
    Osteoporos Int. 2018 Jul 18. pii: 10.1007/s00198-018-4630.
    PubMed     Text format     Abstract available


  15. CHOI CK, Kweon S-, Lee Y-, Nam H-, et al
    Nonlinear association between bone mineral density and all-cause mortality: the Dong-gu study.
    Osteoporos Int. 2018 Jul 16. pii: 10.1007/s00198-018-4386.
    PubMed     Text format     Abstract available


  16. BERGMAN J, Nordstrom A, Nordstrom P
    Bisphosphonate use after clinical fracture and risk of new fracture: response to comments by Wu et al.
    Osteoporos Int. 2018 Jul 16. pii: 10.1007/s00198-018-4615.
    PubMed     Text format    


  17. TREISTER-GOLTZMAN Y, Friger M, Peleg R
    Does primary lactase deficiency reduce bone mineral density in postmenopausal women? A systematic review and meta-analysis.
    Osteoporos Int. 2018 Jul 16. pii: 10.1007/s00198-018-4635.
    PubMed     Text format     Abstract available


  18. CHRISTIANSEN BA, Harrison SL, Fink HA, Lane NE, et al
    Incident fracture is associated with a period of accelerated loss of hip BMD: the Study of Osteoporotic Fractures.
    Osteoporos Int. 2018 Jul 10. pii: 10.1007/s00198-018-4606.
    PubMed     Text format     Abstract available


  19. VELLUCCI R, Terenzi R, Kanis JA, Kress HG, et al
    Understanding osteoporotic pain and its pharmacological treatment: supplementary presentation.
    Osteoporos Int. 2018 Jul 10. pii: 10.1007/s00198-018-4536.
    PubMed     Text format     Abstract available


  20. MO XB, Zhang YH, Lei SF
    Genome-wide identification of m(6)A-associated SNPs as potential functional variants for bone mineral density.
    Osteoporos Int. 2018 Jul 7. pii: 10.1007/s00198-018-4573.
    PubMed     Text format     Abstract available


  21. AMORIM T, Duraes C, Machado JC, Metsios GS, et al
    Genetic variation in Wnt/beta-catenin and ER signalling pathways in female and male elite dancers and its associations with low bone mineral density: a cross-section and longitudinal study.
    Osteoporos Int. 2018 Jul 5. pii: 10.1007/s00198-018-4610.
    PubMed     Text format     Abstract available


  22. WU QY, Yuan FL, Wang B, Li X, et al
    Comments on Bergman et al.: Bisphosphonate use after clinical fracture and risk of new fracture.
    Osteoporos Int. 2018 Jul 5. pii: 10.1007/s00198-018-4614.
    PubMed     Text format    


  23. WINZENRIETH R, Humbert L, Di Gregorio S, Bonel E, et al
    Effects of osteoporosis drug treatments on cortical and trabecular bone in the femur using DXA-based 3D modeling.
    Osteoporos Int. 2018 Jul 4. pii: 10.1007/s00198-018-4624.
    PubMed     Text format     Abstract available


  24. GALLI S, Stocchero M, Andersson M, Karlsson J, et al
    Correction to: The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.
    Osteoporos Int. 2018 Jul 3. pii: 10.1007/s00198-018-4497.
    PubMed     Text format     Abstract available


  25. HO-PHAM LT, Chau PMN, Do AT, Nguyen HC, et al
    Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study.
    Osteoporos Int. 2018 Jul 2. pii: 10.1007/s00198-018-4579.
    PubMed     Text format     Abstract available


  26. SHUDO A, Kishimoto H, Takaoka K, Noguchi K, et al
    Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.
    Osteoporos Int. 2018 Jul 2. pii: 10.1007/s00198-018-4621.
    PubMed     Text format     Abstract available


    June 2018
  27. LIU LC, Lu MC, Wang SY, Livneh H, et al
    Association of use of rehabilitation services with development of osteoporosis among patients with rheumatoid arthritis: a nationwide population-based cohort study.
    Osteoporos Int. 2018 Jun 27. pii: 10.1007/s00198-018-4569.
    PubMed     Text format     Abstract available


  28. SMITH BJ, Leyva MJ, Stephens LD, Aston CE, et al
    Relationship of American Indian blood quantum with osteoporosis risk: a cross-sectional study of American Indian women in Oklahoma.
    Osteoporos Int. 2018 Jun 25. pii: 10.1007/s00198-018-4594.
    PubMed     Text format     Abstract available


  29. GIORDANO S, Proietti A, Bisaccia T, Caso P, et al
    Hypovitaminosis D: comparison between patients with hip fracture and patients with vertebral fractures.
    Osteoporos Int. 2018 Jun 23. pii: 10.1007/s00198-018-4582.
    PubMed     Text format     Abstract available


  30. YOSHIMURA N, Muraki S, Oka H, Iidaka T, et al
    Do sarcopenia and/or osteoporosis increase the risk of frailty? A 4-year observation of the second and third ROAD study surveys.
    Osteoporos Int. 2018 Jun 21. pii: 10.1007/s00198-018-4596.
    PubMed     Text format     Abstract available


  31. SZAFORS P, Che H, Barnetche T, Morel J, et al
    Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis.
    Osteoporos Int. 2018 Jun 16. pii: 10.1007/s00198-018-4586.
    PubMed     Text format     Abstract available


  32. CHEN H, Lips P, Vervloet MG, van Schoor NM, et al
    Association of renal function with bone mineral density and fracture risk in the Longitudinal Aging Study Amsterdam.
    Osteoporos Int. 2018 Jun 15. pii: 10.1007/s00198-018-4592.
    PubMed     Text format     Abstract available


  33. BARTOSCH P, McGuigan FE, Akesson KE
    Progression of frailty and prevalence of osteoporosis in a community cohort of older women-a 10-year longitudinal study.
    Osteoporos Int. 2018 Jun 12. pii: 10.1007/s00198-018-4593.
    PubMed     Text format     Abstract available


  34. HARVEY NC, McCloskey E, Kanis JA, Compston J, et al
    Cost-effective but clinically inappropriate: new NICE intervention thresholds in osteoporosis (Technology Appraisal 464).
    Osteoporos Int. 2018 Jun 8. pii: 10.1007/s00198-018-4505.
    PubMed     Text format     Abstract available


  35. KANIS JA, Cooper C, Rizzoli R, Reginster JY, et al
    Review of the guideline of the American College of Physicians on the treatment of osteoporosis.
    Osteoporos Int. 2018 Jun 4. pii: 10.1007/s00198-018-4504.
    PubMed     Text format     Abstract available


  36. GUPTA MJ, Shah S, Peterson S, Baim S, et al
    Rush Fracture Liaison Service for capturing "missed opportunities" to treat osteoporosis in patients with fragility fractures.
    Osteoporos Int. 2018 Jun 4. pii: 10.1007/s00198-018-4559.
    PubMed     Text format     Abstract available


  37. RIKKONEN T, Poole K, Sirola J, Sund R, et al
    Long-term effects of functional impairment on fracture risk and mortality in postmenopausal women.
    Osteoporos Int. 2018 Jun 2. pii: 10.1007/s00198-018-4588.
    PubMed     Text format     Abstract available


  38. LOSADA E, Soldevila B, Ali MS, Martinez-Laguna D, et al
    Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
    Osteoporos Int. 2018 Jun 2. pii: 10.1007/s00198-018-4581.
    PubMed     Text format     Abstract available


  39. KIM SJ, Park HS, Lee DW, Lee JW, et al
    Is calcium phosphate augmentation a viable option for osteoporotic hip fractures?
    Osteoporos Int. 2018 Jun 1. pii: 10.1007/s00198-018-4572.
    PubMed     Text format     Abstract available


    May 2018
  40. CAI X, Yi X, Zhang Y, Zhang D, et al
    Genetic susceptibility of postmenopausal osteoporosis on sulfide quinone reductase-like gene.
    Osteoporos Int. 2018 May 31. pii: 10.1007/s00198-018-4575.
    PubMed     Text format     Abstract available


  41. LENCHIK L, Register TC, Russell GB, Xu J, et al
    Volumetric bone mineral density of the spine predicts mortality in African-American men with type 2 diabetes.
    Osteoporos Int. 2018 May 31. pii: 10.1007/s00198-018-4578.
    PubMed     Text format     Abstract available


  42. HOFF M, Skurtveit S, Meyer HE, Langhammer A, et al
    Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway.
    Osteoporos Int. 2018 May 17. pii: 10.1007/s00198-018-4560.
    PubMed     Text format     Abstract available


  43. SU Y, Lai FTT, Yip BHK, Leung JCS, et al
    Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.
    Osteoporos Int. 2018 May 17. pii: 10.1007/s00198-018-4543.
    PubMed     Text format     Abstract available


  44. NGUYEN ET, Posas-Mendoza T, Siu AM, Ahn HJ, et al
    Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii.
    Osteoporos Int. 2018 May 9. pii: 10.1007/s00198-018-4553.
    PubMed     Text format     Abstract available


  45. RIZZOLI R, Biver E, Bonjour JP, Coxam V, et al
    Benefits and safety of dietary protein for bone health-an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis
    Osteoporos Int. 2018 May 8. pii: 10.1007/s00198-018-4534.
    PubMed     Text format     Abstract available


  46. GOH SSL, Lai PSM, Tan ATB, Ponnampalavanar S, et al
    Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors: supplementary presentation.
    Osteoporos Int. 2018 May 8. pii: 10.1007/s00198-018-4379.
    PubMed     Text format     Abstract available


  47. BIVER E, Durosier-Izart C, Merminod F, Chevalley T, et al
    Fermented dairy products consumption is associated with attenuated cortical bone loss independently of total calcium, protein, and energy intakes in healthy postmenopausal women.
    Osteoporos Int. 2018 May 3. pii: 10.1007/s00198-018-4535.
    PubMed     Text format     Abstract available


  48. XIAO X, Roohani D, Wu Q
    Genetic profiling of decreased bone mineral density in an independent sample of Caucasian women.
    Osteoporos Int. 2018 May 1. pii: 10.1007/s00198-018-4546.
    PubMed     Text format     Abstract available


    April 2018
  49. THONGPRAYOON C, Acharya P, Acharya C, Chenbhanich J, et al
    Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.
    Osteoporos Int. 2018 Apr 30. pii: 10.1007/s00198-018-4533.
    PubMed     Text format     Abstract available


  50. INDERJEETH CA, Raymond WD, Briggs AM, Geelhoed E, et al
    Implementation of the Western Australian Osteoporosis Model of Care: a fracture liaison service utilising emergency department information systems to identify patients with fragility fracture to improve current practice and reduce re-fracture rates: a
    Osteoporos Int. 2018 Apr 27. pii: 10.1007/s00198-018-4526.
    PubMed     Text format     Abstract available


  51. AHMADI N, Mao SS, Hajsadeghi F, Arnold B, et al
    The relation of low levels of bone mineral density with coronary artery calcium and mortality.
    Osteoporos Int. 2018 Apr 27. pii: 10.1007/s00198-018-4524.
    PubMed     Text format     Abstract available


  52. SHI M, Chen L, Xin Z, Wang Y, et al
    Bisphosphonates for the preservation of periprosthetic bone mineral density after total joint arthroplasty: a meta-analysis of 25 randomized controlled trials.
    Osteoporos Int. 2018 Apr 13. pii: 10.1007/s00198-018-4488.
    PubMed     Text format     Abstract available


  53. SU Y, Leung J, Kwok T
    The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2018 Apr 12. pii: 10.1007/s00198-017-4373.
    PubMed     Text format     Abstract available


  54. CLARK EM, Gooberman-Hill R, Peters TJ
    Correction to: Using self-reports of pain and other variables to distinguish between older women with back pain due to vertebral fractures and those with back pain due to degenerative changes.
    Osteoporos Int. 2018 Apr 12. pii: 10.1007/s00198-018-4495.
    PubMed     Text format     Abstract available


  55. KOSTEV K
    Association between gout and osteoporosis risk in the United Kingdom.
    Osteoporos Int. 2018 Apr 10. pii: 10.1007/s00198-018-4477.
    PubMed     Text format    


  56. KOK VC
    Gout as a risk factor for osteoporosis: response to comments by Kostev.
    Osteoporos Int. 2018 Apr 10. pii: 10.1007/s00198-018-4478.
    PubMed     Text format    


  57. LIU Y, Levack AE, Marty E, Or O, et al
    Anabolic agents: what is beyond osteoporosis?
    Osteoporos Int. 2018 Apr 7. pii: 10.1007/s00198-018-4507.
    PubMed     Text format     Abstract available


  58. KEMMLER W, Shojaa M, Kohl M, von Stengel S, et al
    Exercise effects on bone mineral density in older men: a systematic review with special emphasis on study interventions.
    Osteoporos Int. 2018 Apr 5. pii: 10.1007/s00198-018-4482.
    PubMed     Text format     Abstract available


  59. VELLUCCI R, Terenzi R, Kanis JA, Kress HG, et al
    Understanding osteoporotic pain and its pharmacological treatment.
    Osteoporos Int. 2018 Apr 4. pii: 10.1007/s00198-018-4476.
    PubMed     Text format     Abstract available



  60. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  61. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Author Index.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  62. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): ESCEO Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  63. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Plenary Lectures Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  64. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Educational Lecture Abstract.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  65. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): IOF-ESCEO Symposium Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  66. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Satellite Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  67. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): ESCEO-WHO Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  68. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Oral Communication Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  69. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): EUGMS-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  70. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): ESPRM-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  71. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Meet-the-Expert Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  72. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Non-Sponsored Symposia Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    



  73. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Committee of National Societies Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    


  74. ROSEVEARE D
    World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018): Poster Abstracts.
    Osteoporos Int. 2018;29.
    PubMed     Text format    


    March 2018
  75. BUTSCHEIDT S, Delsmann A, Rolvien T, Barvencik F, et al
    Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2.
    Osteoporos Int. 2018 Mar 29. pii: 10.1007/s00198-018-4499.
    PubMed     Text format     Abstract available


  76. WANG D, Ruan W, Peng Y, Li W, et al
    Sleep duration and the risk of osteoporosis among middle-aged and elderly adults: a dose-response meta-analysis.
    Osteoporos Int. 2018 Mar 25. pii: 10.1007/s00198-018-4487.
    PubMed     Text format     Abstract available


  77. XIAO X, Xu Y, Wu Q
    Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies.
    Osteoporos Int. 2018 Mar 25. pii: 10.1007/s00198-018-4486.
    PubMed     Text format     Abstract available


  78. KUMAGAI K, Harigane K, Kusayama Y, Tezuka T, et al
    Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison.
    Osteoporos Int. 2018 Mar 24. pii: 10.1007/s00198-018-4494.
    PubMed     Text format     Abstract available


  79. EBINA K, Hirao M, Hashimoto J, Matsuoka H, et al
    Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naive rheumatoid arthritis.
    Osteoporos Int. 2018 Mar 24. pii: 10.1007/s00198-018-4492.
    PubMed     Text format     Abstract available


  80. GRAUMAM RQ, Pinheiro MM, Nery LE, Castro CHM, et al
    Increased rate of osteoporosis, low lean mass, and fragility fractures in COPD patients: association with disease severity.
    Osteoporos Int. 2018 Mar 21. pii: 10.1007/s00198-018-4483.
    PubMed     Text format     Abstract available


  81. ALEKSOVA J, Kurniawan S, Elder GJ
    The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.
    Osteoporos Int. 2018 Mar 19. pii: 10.1007/s00198-018-4468.
    PubMed     Text format     Abstract available


  82. WU Q, Liu B, Tonmoy S
    Depression and risk of fracture and bone loss: an updated meta-analysis of prospective studies.
    Osteoporos Int. 2018 Mar 12. pii: 10.1007/s00198-018-4420.
    PubMed     Text format     Abstract available


  83. NAYLOR KE, Bradburn M, Paggiosi MA, Gossiel F, et al
    Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.
    Osteoporos Int. 2018 Mar 10. pii: 10.1007/s00198-018-4460.
    PubMed     Text format     Abstract available


  84. LEVIN VA, Jiang X, Kagan R
    Estrogen therapy for osteoporosis in the modern era.
    Osteoporos Int. 2018 Mar 8. pii: 10.1007/s00198-018-4414.
    PubMed     Text format     Abstract available


  85. LUO Y
    Bone mineral density averaged over a region of interest on femur is affected by age-related change of bone geometry.
    Osteoporos Int. 2018 Mar 5. pii: 10.1007/s00198-018-4461.
    PubMed     Text format     Abstract available


  86. SEGAUD N, Legroux I, Hazzan M, Noel C, et al
    Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
    Osteoporos Int. 2018 Mar 2. pii: 10.1007/s00198-018-4383.
    PubMed     Text format     Abstract available


    February 2018
  87. UENISHI K, Tokiwa M, Kato S, Shiraki M, et al
    Correction to: Stimulation of intestinal calcium absorption by orally administrated vitamin D3 compounds: a prospective open-label randomized trial in osteoporosis.
    Osteoporos Int. 2018 Feb 26. pii: 10.1007/s00198-018-4449.
    PubMed     Text format     Abstract available


  88. UEI H, Tokuhashi Y, Maseda M, Nakahashi M, et al
    Multiple vertebral fractures associated with glucocorticoid-induced osteoporosis treated with teriparatide followed by kyphosis correction fusion: a case report.
    Osteoporos Int. 2018 Feb 23. pii: 10.1007/s00198-018-4425.
    PubMed     Text format     Abstract available


  89. GUIRANT L, Carlos F, Curiel D, Kanis JA, et al
    Health-related quality of life during the first year after a hip fracture: results of the Mexican arm of the International Cost and Utility Related to Osteoporotic Fractures Study (MexICUROS).
    Osteoporos Int. 2018 Feb 20. pii: 10.1007/s00198-018-4389.
    PubMed     Text format     Abstract available


  90. KUIPER BW, Graybill S, Tate JM, Kaufman N, et al
    After the fall: improving osteoporosis treatment following hip fracture.
    Osteoporos Int. 2018 Feb 20. pii: 10.1007/s00198-018-4416.
    PubMed     Text format     Abstract available


  91. MARCUS R
    Comments on Galli et al.: The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-017-4177.
    PubMed     Text format    


  92. LEE CK, Choi SK, Shin DA, Yi S, et al
    Parkinson's disease and the risk of osteoporotic vertebral compression fracture: a nationwide population-based study.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4409.
    PubMed     Text format     Abstract available


  93. KARJALAINEN JP, Riekkinen O, Kroger H
    Pulse-echo ultrasound method for detection of post-menopausal women with osteoporotic BMD.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4408.
    PubMed     Text format     Abstract available


  94. GALLI S
    The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation: response to comments by Marcus.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4430.
    PubMed     Text format    


  95. BINKLEY N, Krueger D, de Papp AE
    Multiple vertebral fractures following osteoporosis treatment discontinuation: a case-report after long-term Odanacatib.
    Osteoporos Int. 2018 Feb 18. pii: 10.1007/s00198-018-4385.
    PubMed     Text format     Abstract available


  96. ROGERS TS, Harrison S, Judd S, Orwoll ES, et al
    Dietary patterns and longitudinal change in hip bone mineral density among older men.
    Osteoporos Int. 2018 Feb 15. pii: 10.1007/s00198-018-4388.
    PubMed     Text format     Abstract available


  97. ROUX S, Gaboury I, Gionet-Landry N, Garant MP, et al
    Using a sequential explanatory mixed method to evaluate the therapeutic window of opportunity for initiating osteoporosis treatment following fragility fractures.
    Osteoporos Int. 2018 Feb 14. pii: 10.1007/s00198-017-4374.
    PubMed     Text format     Abstract available


  98. ZHOU C, Fang L, Chen Y, Zhong J, et al
    Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
    Osteoporos Int. 2018 Feb 12. pii: 10.1007/s00198-018-4413.
    PubMed     Text format     Abstract available


  99. MORI Y, Kasai H, Ose A, Serada M, et al
    Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
    Osteoporos Int. 2018 Feb 8. pii: 10.1007/s00198-018-4376.
    PubMed     Text format     Abstract available


  100. LESLIE WD, Majumdar SR, Morin SN, Lix LM, et al
    Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
    Osteoporos Int. 2018 Feb 5. pii: 10.1007/s00198-018-4415.
    PubMed     Text format     Abstract available



  101. Erratum to: World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Poster Abstracts.
    Osteoporos Int. 2018 Feb 5. pii: 10.1007/s00198-017-4135.
    PubMed     Text format     Abstract available


  102. HAMDY RC, Seier E, Whalen K, Clark WA, et al
    FRAX calculated without BMD does not correctly identify Caucasian men with densitometric evidence of osteoporosis.
    Osteoporos Int. 2018 Feb 3. pii: 10.1007/s00198-017-4368.
    PubMed     Text format     Abstract available


  103. BERGMAN J, Nordstrom A, Nordstrom P
    Bisphosphonate use after clinical fracture and risk of new fracture.
    Osteoporos Int. 2018 Feb 3. pii: 10.1007/s00198-017-4367.
    PubMed     Text format     Abstract available


    January 2018
  104. KOK VC, Horng JT, Wang MN, Chen ZY, et al
    Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals.
    Osteoporos Int. 2018 Jan 30. pii: 10.1007/s00198-018-4375.
    PubMed     Text format     Abstract available


  105. WRIGHT NC, Hooker ER, Nielson CM, Ensrud KE, et al
    The epidemiology of wrist fractures in older men: the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2018 Jan 17. pii: 10.1007/s00198-017-4349.
    PubMed     Text format     Abstract available


  106. NEWMAN M, Newman R, Hughes T, Vadher K, et al
    Is the timed loaded standing test a valid measure of back muscle endurance in people with vertebral osteoporosis?
    Osteoporos Int. 2018 Jan 10. pii: 10.1007/s00198-017-4358.
    PubMed     Text format     Abstract available


  107. MOOKIAH MRK, Rohrmeier A, Dieckmeyer M, Mei K, et al
    Feasibility of opportunistic osteoporosis screening in routine contrast-enhanced multi detector computed tomography (MDCT) using texture analysis.
    Osteoporos Int. 2018 Jan 10. pii: 10.1007/s00198-017-4342.
    PubMed     Text format     Abstract available


  108. VARAHRA A, Rodrigues IB, MacDermid JC, Bryant D, et al
    Exercise to improve functional outcomes in persons with osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2018 Jan 6. pii: 10.1007/s00198-017-4339.
    PubMed     Text format     Abstract available


    December 2017
  109. CHANG Y-, Huang C-, Hwang J-, Kuo J-, et al
    Fracture liaison services for osteoporosis in the Asia-Pacific region: current unmet needs and systematic literature review.
    Osteoporos Int. 2017 Dec 28. pii: 10.1007/s00198-017-4347.
    PubMed     Text format     Abstract available


  110. UENISHI K, Tokiwa M, Kato S, Shiraki M, et al
    Stimulation of intestinal calcium absorption by orally administrated vitamin D3 compounds: a prospective open-label randomized trial in osteoporosis.
    Osteoporos Int. 2017 Dec 23. pii: 10.1007/s00198-017-4351.
    PubMed     Text format     Abstract available


  111. TAMIMI I, Nicolau B, Eimar H, Arekunnath Madathil S, et al
    Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study.
    Osteoporos Int. 2017 Dec 20. pii: 10.1007/s00198-017-4346.
    PubMed     Text format     Abstract available


  112. LUTHMAN S, Widen J, Borgstrom F
    Appropriateness criteria for treatment of osteoporotic vertebral compression fractures.
    Osteoporos Int. 2017 Dec 19. pii: 10.1007/s00198-017-4348.
    PubMed     Text format     Abstract available


  113. VAN DEN BERG P, van Haard PMM, van der Veer E, Geusens PP, et al
    A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates.
    Osteoporos Int. 2017 Dec 19. pii: 10.1007/s00198-017-4340.
    PubMed     Text format     Abstract available


  114. HTET TD, Eisman JA, Elder GJ, Center JR, et al
    Worsening of soft tissue dystrophic calcification in an osteoporotic patient treated with teriparatide.
    Osteoporos Int. 2017 Dec 15. pii: 10.1007/s00198-017-4330.
    PubMed     Text format     Abstract available


  115. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis.
    Osteoporos Int. 2017 Dec 11. pii: 10.1007/s00198-017-4334.
    PubMed     Text format     Abstract available


  116. RUBIN KH, Rothmann MJ, Holmberg T, Hoiberg M, et al
    Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study.
    Osteoporos Int. 2017 Dec 7. pii: 10.1007/s00198-017-4326.
    PubMed     Text format     Abstract available


  117. WATANABE R, Shiraki M, Saito M, Okazaki R, et al
    Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women.
    Osteoporos Int. 2017 Dec 7. pii: 10.1007/s00198-017-4337.
    PubMed     Text format     Abstract available


  118. BOSKEY AL, Spevak L, Ma Y, Wang H, et al
    Insights into the bisphosphonate holiday: a preliminary FTIRI study.
    Osteoporos Int. 2017 Dec 5. pii: 10.1007/s00198-017-4324.
    PubMed     Text format     Abstract available


  119. MARTIN-MERINO E, Petersen I, Hawley S, Alvarez-Gutierrez A, et al
    Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK.
    Osteoporos Int. 2017 Dec 3. pii: 10.1007/s00198-017-4308.
    PubMed     Text format     Abstract available


  120. AREECKAL AS, Jayasheelan N, Kamath J, Zawadynski S, et al
    Early diagnosis of osteoporosis using radiogrammetry and texture analysis from hand and wrist radiographs in Indian population.
    Osteoporos Int. 2017 Dec 3. pii: 10.1007/s00198-017-4328.
    PubMed     Text format     Abstract available


  121. JONSSON E, Hansson-Hedblom A, Ljunggren O, Akesson K, et al
    A health economic simulation model for the clinical management of osteoporosis.
    Osteoporos Int. 2017 Dec 1. pii: 10.1007/s00198-017-4325.
    PubMed     Text format     Abstract available


    November 2017
  122. BREDEMEIER M
    Comments on Mignot et al.: bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Osteoporos Int. 2017 Nov 27. pii: 10.1007/s00198-017-4263.
    PubMed     Text format    


  123. PACCOU J, Cortet B
    Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk. Response to comments by Bredemeier.
    Osteoporos Int. 2017 Nov 27. pii: 10.1007/s00198-017-4320.
    PubMed     Text format    


  124. NOGUES X, Nolla JM, Casado E, Jodar E, et al
    Spanish consensus on treat to target for osteoporosis.
    Osteoporos Int. 2017 Nov 24. pii: 10.1007/s00198-017-4310.
    PubMed     Text format     Abstract available


  125. VRANKEN L, Wyers CE, Van der Velde RY, Janzing HM, et al
    Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service.
    Osteoporos Int. 2017 Nov 23. pii: 10.1007/s00198-017-4290.
    PubMed     Text format     Abstract available


  126. YANG L, Parimi N, Orwoll ES, Black DM, et al
    Association of incident hip fracture with the estimated femoral strength by finite element analysis of DXA scans in the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2017 Nov 22. doi: 10.1007/s00198-017-4319.
    PubMed     Text format     Abstract available


  127. WATANABE R, Tai N, Hirano J, Ban Y, et al
    Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease.
    Osteoporos Int. 2017 Nov 22. doi: 10.1007/s00198-017-4314.
    PubMed     Text format     Abstract available


  128. GOH SSL, Lai PSM, Tan ATB, Ponnampalavanar S, et al
    Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Osteoporos Int. 2017 Nov 20. doi: 10.1007/s00198-017-4305.
    PubMed     Text format     Abstract available


  129. MAKITIE RE, Niinimaki R, Kakko S, Honkanen T, et al
    Defective WNT signaling associates with bone marrow fibrosis-a cross-sectional cohort study in a family with WNT1 osteoporosis.
    Osteoporos Int. 2017 Nov 16. doi: 10.1007/s00198-017-4309.
    PubMed     Text format     Abstract available


  130. JOHANSSON L, Sundh D, Nilsson M, Mellstrom D, et al
    Vertebral fractures and their association with health-related quality of life, back pain and physical function in older women.
    Osteoporos Int. 2017 Nov 15. doi: 10.1007/s00198-017-4296.
    PubMed     Text format     Abstract available


  131. CHENBHANICH J, Thongprayoon C, Atsawarungruangkit A, Phupitakphol T, et al
    Osteoporosis and bone mineral density in patients with Wilson's disease: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Nov 6. doi: 10.1007/s00198-017-4295.
    PubMed     Text format     Abstract available


  132. MODI A, Sen S, Adachi JD, Adami S, et al
    The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study.
    Osteoporos Int. 2017 Nov 6. doi: 10.1007/s00198-017-4271.
    PubMed     Text format     Abstract available


  133. AL-SARI UA, Tobias JH, Clark EM
    Self-reported everyday physical activities in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4287.
    PubMed     Text format     Abstract available


  134. KAZE AD, Rosen HN, Paik JM
    A meta-analysis of the association between body mass index and risk of vertebral fracture.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4294.
    PubMed     Text format     Abstract available


    October 2017
  135. SCHOUSBOE JT, Vo TN, Langsetmo L, Taylor BC, et al
    Predictors of change of trabecular bone score (TBS) in older men: results from the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2017 Oct 31. doi: 10.1007/s00198-017-4273.
    PubMed     Text format     Abstract available


  136. GREENSPAN SL, Vujevich K, Britton C, Herradura A, et al
    Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.
    Osteoporos Int. 2017 Oct 30. doi: 10.1007/s00198-017-4286.
    PubMed     Text format     Abstract available


  137. RUPPERT K, Cauley J, Lian Y, Zgibor JC, et al
    The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study.
    Osteoporos Int. 2017 Oct 27. doi: 10.1007/s00198-017-4276.
    PubMed     Text format     Abstract available


  138. SPIERINGS J, Bours S, Peeters HRM
    A case of regional migratory osteoporosis.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4240.
    PubMed     Text format     Abstract available


  139. RATHBUN AM, Magaziner J, Shardell MD, Yerges-Armstrong LM, et al
    Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4280.
    PubMed     Text format     Abstract available


  140. SU Y, Leung J, Kwok T
    The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4277.
    PubMed     Text format     Abstract available


  141. DUNN P, Webb D, Olenginski TP
    Geisinger high-risk osteoporosis clinic (HiROC): 2013-2015 FLS performance analysis.
    Osteoporos Int. 2017 Oct 23. doi: 10.1007/s00198-017-4270.
    PubMed     Text format     Abstract available


  142. DONG XL, Yu WX, Li CM, He S, et al
    Danshen (Salvia miltiorrhiza) protects ovariectomized rats fed with high-saturated fat-sucrose diet from bone loss.
    Osteoporos Int. 2017 Oct 23. doi: 10.1007/s00198-017-4254.
    PubMed     Text format     Abstract available


  143. AHN SH, Seo DH, Kim SH, Nam MS, et al
    The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011.
    Osteoporos Int. 2017 Oct 19. doi: 10.1007/s00198-017-4257.
    PubMed     Text format     Abstract available


  144. KASTNER M, Perrier L, Munce SEP, Adhihetty CC, et al
    Complex interventions can increase osteoporosis investigations and treatment: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Oct 18. doi: 10.1007/s00198-017-4248.
    PubMed     Text format     Abstract available


  145. MALMGREN L, McGuigan F, Christensson A, Akesson KE, et al
    Reduced kidney function is associated with BMD, bone loss and markers of mineral homeostasis in older women: a 10-year longitudinal study.
    Osteoporos Int. 2017 Oct 16. doi: 10.1007/s00198-017-4221.
    PubMed     Text format     Abstract available


  146. LIN SM, Yang SH, Liang CC, Huang HK, et al
    Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Osteoporos Int. 2017 Oct 14. doi: 10.1007/s00198-017-4262.
    PubMed     Text format     Abstract available


  147. BINKLEY N, Besuyen R, Fuerst T, Skillern L, et al
    Is drug-induced bone loss acceptable in premenopausal women? A practical fracture risk modeling exercise.
    Osteoporos Int. 2017 Oct 10. doi: 10.1007/s00198-017-4258.
    PubMed     Text format     Abstract available


  148. MALLUCHE HH, Monier-Faugere MC, Blomquist G, Davenport DL, et al
    Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.
    Osteoporos Int. 2017 Oct 9. doi: 10.1007/s00198-017-4228.
    PubMed     Text format     Abstract available


  149. TSENG OL, Dawes MG, Spinelli JJ, Gotay CC, et al
    Utilization of bone mineral density testing among breast cancer survivors in British Columbia, Canada.
    Osteoporos Int. 2017 Oct 9. doi: 10.1007/s00198-017-4218.
    PubMed     Text format     Abstract available


  150. RODRIGUEZ AJ, Scott D, Ebeling PR
    Comments on Li et al.: Meta-analysis of hypertension and osteoporotic fracture risk in women and men.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4246.
    PubMed     Text format    


  151. LI C, Wang Q
    Meta-analysis of hypertension and osteoporotic fracture risk in women and men: response to comments by Rodriguez et al.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4245.
    PubMed     Text format    


  152. YANG S, Leslie WD, Luo Y, Goertzen AL, et al
    Automated DXA-based finite element analysis for hip fracture risk stratification: a cross-sectional study.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4232.
    PubMed     Text format     Abstract available


  153. ZANCHETTA MB, Boailchuk J, Massari F, Silveira F, et al
    Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study.
    Osteoporos Int. 2017 Oct 3. doi: 10.1007/s00198-017-4242.
    PubMed     Text format     Abstract available


  154. MACK DE, Wilson PM, Santos E, Brooks K, et al
    Standards of reporting: the use of CONSORT PRO and CERT in individuals living with osteoporosis.
    Osteoporos Int. 2017 Oct 2. doi: 10.1007/s00198-017-4249.
    PubMed     Text format     Abstract available


  155. DALLA VIA J, Daly RM, Fraser SF
    The effect of exercise on bone mineral density in adult cancer survivors: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Oct 2. doi: 10.1007/s00198-017-4237.
    PubMed     Text format     Abstract available


    September 2017
  156. FREDERIKSEN A, Abrahamsen B, Johansen PB, Sorensen HA, et al
    Danish, national cross-sectional observational study on the prevalence of prior major osteoporotic fractures in adults presenting with hip fracture-limitations and scope for fracture liaison services in prevention of hip fracture.
    Osteoporos Int. 2017 Sep 30. doi: 10.1007/s00198-017-4247.
    PubMed     Text format     Abstract available


  157. KYVERNITAKIS I, Reuter TC, Hellmeyer L, Hars O, et al
    Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.
    Osteoporos Int. 2017 Sep 30. doi: 10.1007/s00198-017-4239.
    PubMed     Text format     Abstract available


  158. HOLLOWAY KL, Mohebbi M, Betson AG, Hans D, et al
    Prediction of major osteoporotic and hip fractures in Australian men using FRAX scores adjusted with trabecular bone score.
    Osteoporos Int. 2017 Sep 23. doi: 10.1007/s00198-017-4226.
    PubMed     Text format     Abstract available


  159. WRIGHT NC, Saag KG, Dawson-Hughes B, Khosla S, et al
    The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation.
    Osteoporos Int. 2017 Sep 21. doi: 10.1007/s00198-017-4207.
    PubMed     Text format     Abstract available


  160. LARSEN AU, Grimnes G, Jorde R
    The effect of high-dose vitamin D3 supplementation on bone mineral density in subjects with prediabetes.
    Osteoporos Int. 2017 Sep 18. doi: 10.1007/s00198-017-4222.
    PubMed     Text format     Abstract available


  161. BRIOT K, Geusens P, Em Bultink I, Lems WF, et al
    Inflammatory diseases and bone fragility.
    Osteoporos Int. 2017 Sep 15. doi: 10.1007/s00198-017-4189.
    PubMed     Text format     Abstract available


  162. ANSARI H, Beaton DE, Sujic R, Rotondi NK, et al
    Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening program.
    Osteoporos Int. 2017 Sep 10. doi: 10.1007/s00198-017-4206.
    PubMed     Text format     Abstract available


  163. NGUYEN VT, Edmonds SW, Lou Y, Roblin DW, et al
    Validity, reliability, and responsiveness to change of the "Osteoporosis and You" knowledge scale.
    Osteoporos Int. 2017 Sep 7. doi: 10.1007/s00198-017-4204.
    PubMed     Text format     Abstract available


  164. CALLEGARI ET, Garland SM, Gorelik A, Wark JD, et al
    Erratum to: Determinants of bone mineral density in young Australian women; results from the Safe-D study.
    Osteoporos Int. 2017 Sep 6. doi: 10.1007/s00198-017-4210.
    PubMed     Text format    


  165. ROTHMANN MJ, Moller S, Holmberg T, Hojberg M, et al
    Non-participation in systematic screening for osteoporosis-the ROSE trial.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4205.
    PubMed     Text format     Abstract available


  166. MIGNOT MA, Taisne N, Legroux I, Cortet B, et al
    Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4215.
    PubMed     Text format     Abstract available


  167. KAEWBOONCHOO O, Sung FC, Lin CL, Hsu HC, et al
    Hip fracture risk in patients with burn injury: a retrospective cohort study in Taiwan.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4209.
    PubMed     Text format     Abstract available


  168. CELLI M, D'Eufemia P, Persiani P, Turchetti A, et al
    Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
    Osteoporos Int. 2017 Sep 2. doi: 10.1007/s00198-017-4214.
    PubMed     Text format     Abstract available


    August 2017
  169. LITWIC AE, Compston JE, Wyman A, Siris ES, et al
    Self-perception of fracture risk: what can it tell us?
    Osteoporos Int. 2017 Aug 31. doi: 10.1007/s00198-017-4200.
    PubMed     Text format     Abstract available


  170. ROUX C, Baron G, Briot K, Roux B, et al
    Management of oral bisphosphonates treatment by rheumatologists and determinants of therapeutic changes: a case-vignette-based study.
    Osteoporos Int. 2017 Aug 29. doi: 10.1007/s00198-017-4188.
    PubMed     Text format     Abstract available


  171. MALGO F, Hamdy NAT, Ticheler CHJM, Smit F, et al
    Value and potential limitations of vertebral fracture assessment (VFA) compared to conventional spine radiography: experience from a fracture liaison service (FLS) and a meta-analysis.
    Osteoporos Int. 2017 Aug 25. doi: 10.1007/s00198-017-4137.
    PubMed     Text format     Abstract available


  172. MIYAKOSHI N, Kudo D, Hongo M, Kasukawa Y, et al
    Comparison of spinal alignment, muscular strength, and quality of life between women with postmenopausal osteoporosis and healthy volunteers.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4184.
    PubMed     Text format     Abstract available


  173. KANIS JA, Cooper C, Rizzoli R, Abrahamsen B, et al
    Erratum to: Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4161.
    PubMed     Text format    


  174. JOHANSSON H, Azizieh F, Al Ali N, Alessa T, et al
    FRAX- vs. T-score-based intervention thresholds for osteoporosis.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4160.
    PubMed     Text format     Abstract available


  175. SAITO T, Sterbenz JM, Malay S, Zhong L, et al
    Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis.
    Osteoporos Int. 2017 Aug 2. doi: 10.1007/s00198-017-4175.
    PubMed     Text format     Abstract available


    July 2017
  176. CHOU L, Shamdasani P, Briggs AM, Cicuttini FM, et al
    Systematic scoping review of patients' perceived needs of health services for osteoporosis.
    Osteoporos Int. 2017 Jul 31. doi: 10.1007/s00198-017-4167.
    PubMed     Text format     Abstract available


  177. WILLIAMS ST, Lawrence PT, Miller KL, Crook JL, et al
    A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis.
    Osteoporos Int. 2017 Jul 30. doi: 10.1007/s00198-017-4172.
    PubMed     Text format     Abstract available


  178. KOH JH, Myong JP, Yoo J, Lim YW, et al
    Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Osteoporos Int. 2017 Jul 27. doi: 10.1007/s00198-017-4169.
    PubMed     Text format     Abstract available


  179. KAMPE AJ, Costantini A, Makitie RE, Jantti N, et al
    PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4150.
    PubMed     Text format     Abstract available


  180. MCCLUNG MR, Lippuner K, Brandi ML, Zanchetta JR, et al
    Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4140.
    PubMed     Text format     Abstract available


  181. VAN DER VELDE RY, Bours SPG, Wyers CE, Lems WF, et al
    Effect of implementation of guidelines on assessment and diagnosis of vertebral fractures in patients older than 50 years with a recent non-vertebral fracture.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4147.
    PubMed     Text format     Abstract available


  182. ZENG Y, Zhang L, Zhu W, He H, et al
    Network based subcellular proteomics in monocyte membrane revealed novel candidate genes involved in osteoporosis.
    Osteoporos Int. 2017 Jul 24. doi: 10.1007/s00198-017-4146.
    PubMed     Text format     Abstract available


  183. POP LM, Lingvay I, Yuan Q, Li X, et al
    Impact of pioglitazone on bone mineral density and bone marrow fat content.
    Osteoporos Int. 2017 Jul 22. doi: 10.1007/s00198-017-4164.
    PubMed     Text format     Abstract available


  184. NASIRI SARVI M, Luo Y
    Sideways fall-induced impact force and its effect on hip fracture risk: a review.
    Osteoporos Int. 2017 Jul 20. doi: 10.1007/s00198-017-4138.
    PubMed     Text format     Abstract available


  185. REYES C, Tebe C, Martinez-Laguna D, Ali MS, et al
    One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study.
    Osteoporos Int. 2017 Jul 16. doi: 10.1007/s00198-017-4144.
    PubMed     Text format     Abstract available


  186. DRIESSEN JHM, Knapen LM, Geusens PPMM, van den Bergh JPW, et al
    Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?
    Osteoporos Int. 2017 Jul 13. doi: 10.1007/s00198-017-4120.
    PubMed     Text format    


  187. KOSTEV K, Dombrowski S
    Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: response to Driessen et al.
    Osteoporos Int. 2017 Jul 13. doi: 10.1007/s00198-017-4139.
    PubMed     Text format    


  188. COSMAN F
    Spine fracture prevalence in a nationally representative sample of US women and men aged >/=40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014---supplementary presentation.
    Osteoporos Int. 2017 Jul 10. doi: 10.1007/s00198-017-3999.
    PubMed     Text format     Abstract available


  189. SHI L, Gao F, Sun W, Wang B, et al
    Short-term effects of extracorporeal shock wave therapy on bone mineral density in postmenopausal osteoporotic patients.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4136.
    PubMed     Text format     Abstract available


  190. NGUYEN VH
    Osteoporosis exercise knowledge and education in medicine and nursing.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4119.
    PubMed     Text format    


  191. GIANGREGORIO L, Clark R, McArthur C, Papaioannou A, et al
    Osteoporosis exercise knowledge and education in medicine and nursing: response to comments by Nguyen.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4121.
    PubMed     Text format    


  192. XUE F, Goli V, Petraro P, McMullan T, et al
    Marginal structural model to evaluate the association between cumulative osteoporosis medication and infection using claims data.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4129.
    PubMed     Text format     Abstract available


  193. CARFI A, Liperoti R, Fusco D, Giovannini S, et al
    Bone mineral density in adults with Down syndrome.
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4133.
    PubMed     Text format     Abstract available


  194. HANUSCH BC, Tuck SP, McNally RJQ, Wu JJ, et al
    Does regional loss of bone density explain low trauma distal forearm fractures in men (the Mr F study)?
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4122.
    PubMed     Text format     Abstract available



  195. WORLD CONGRESS ON OSTEOPOROSIS, OSTEOARTHRITIS AND MUSCULOSKELETAL DISEASES.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  196. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Author Index.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  197. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): ESCEO Symposia Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  198. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Meet-the-Experts Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  199. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Plenary Lectures Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  200. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Honorary Lecture Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  201. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Oral Communication Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  202. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Satellite Symposia Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  203. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Educational Lecture Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  204. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Non-sponsored Symposia Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  205. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Committee of National Societies Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  206. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): World Health Organization (WHO) Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    



  207. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2017): Poster Abstracts.
    Osteoporos Int. 2017;28.
    PubMed     Text format    


    June 2017
  208. MENDIS AS, Ganda K, Seibel MJ
    Barriers to secondary fracture prevention in primary care.
    Osteoporos Int. 2017 Jun 29. doi: 10.1007/s00198-017-4131.
    PubMed     Text format     Abstract available


  209. CALLEGARI ET, Garland SM, Gorelik A, Wark JD, et al
    Determinants of bone mineral density in young Australian women; results from the Safe-D study.
    Osteoporos Int. 2017 Jun 28. doi: 10.1007/s00198-017-4100.
    PubMed     Text format     Abstract available


  210. AMORIM T, Koutedakis Y, Nevill A, Wyon M, et al
    Bone mineral density in vocational and professional ballet dancers.
    Osteoporos Int. 2017 Jun 27. doi: 10.1007/s00198-017-4130.
    PubMed     Text format     Abstract available


  211. FISCHER S, Kapinos KA, Mulcahy A, Pinto L, et al
    Estimating the long-term functional burden of osteoporosis-related fractures.
    Osteoporos Int. 2017 Jun 24. doi: 10.1007/s00198-017-4110.
    PubMed     Text format     Abstract available


  212. LOGAN S, Thu WPP, Lay WK, Wang LY, et al
    Chronic joint pain and handgrip strength correlates with osteoporosis in mid-life women: a Singaporean cohort.
    Osteoporos Int. 2017 Jun 24. doi: 10.1007/s00198-017-4095.
    PubMed     Text format     Abstract available


  213. KURODA T, Ohta H, Onoe Y, Tsugawa N, et al
    Intake of omega-3 fatty acids contributes to bone mineral density at the hip in a younger Japanese female population.
    Osteoporos Int. 2017 Jun 23. doi: 10.1007/s00198-017-4128.
    PubMed     Text format     Abstract available


  214. MODI A, Sen S, Adachi JD, Adami S, et al
    Association of gastrointestinal events with quality of life and treatment satisfaction in osteoporosis patients: results from the Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC OS).
    Osteoporos Int. 2017 Jun 22. doi: 10.1007/s00198-017-4116.
    PubMed     Text format     Abstract available


  215. OSHAGBEMI OA, Driessen JHM, Pieffers A, Wouters EFM, et al
    Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis.
    Osteoporos Int. 2017 Jun 21. doi: 10.1007/s00198-017-4115.
    PubMed     Text format     Abstract available


  216. LV F, Ma M, Liu W, Xu X, et al
    A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid.
    Osteoporos Int. 2017 Jun 16. doi: 10.1007/s00198-017-4094.
    PubMed     Text format     Abstract available


  217. WEYCKER D, Edelsberg J, Barron R, Atwood M, et al
    Predictors of near-term fracture in osteoporotic women aged >/=65 years, based on data from the study of osteoporotic fractures.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4103.
    PubMed     Text format     Abstract available


  218. WRIGHT NC, Foster PJ, Mudano AS, Melnick JA, et al
    Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4105.
    PubMed     Text format    


  219. SVENSSON HK, Olsson L-, Hansson T, Karlsson J, et al
    The effects of person-centered or other supportive interventions in older women with osteoporotic vertebral compression fractures-a systematic review of the literature.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4099.
    PubMed     Text format     Abstract available


  220. BLANCO E, Burrows R, Reyes M, Lozoff B, et al
    Breastfeeding as the sole source of milk for 6 months and adolescent bone mineral density.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4106.
    PubMed     Text format     Abstract available


  221. LEHMANN T, Aeberli D
    Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4108.
    PubMed     Text format    


  222. SHIEK AHMAD B, Petty SJ, Gorelik A, O'Brien TJ, et al
    Bone loss with antiepileptic drug therapy: a twin and sibling study.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4098.
    PubMed     Text format     Abstract available


  223. COULSON J, Bagley L, Barnouin Y, Bradburn S, et al
    Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.
    Osteoporos Int. 2017 Jun 5. doi: 10.1007/s00198-017-4104.
    PubMed     Text format     Abstract available


  224. GIFRE L, Ruiz-Gaspa S, Carrasco JL, Portell E, et al
    Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy.
    Osteoporos Int. 2017 Jun 4. doi: 10.1007/s00198-017-4090.
    PubMed     Text format     Abstract available


  225. SHAH VN, Harrall KK, Shah CS, Gallo TL, et al
    Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature.
    Osteoporos Int. 2017 Jun 3. doi: 10.1007/s00198-017-4097.
    PubMed     Text format     Abstract available


  226. SAHNI S, Soedamah-Muthu SS, Weaver CM
    Higher milk intake increases fracture risk: confounding or true association?
    Osteoporos Int. 2017 Jun 1. doi: 10.1007/s00198-017-4088.
    PubMed     Text format    


    May 2017
  227. CUI L, Chen L, Xia W, Jiang Y, et al
    Vertebral fracture in postmenopausal Chinese women: a population-based study.
    Osteoporos Int. 2017 May 30. doi: 10.1007/s00198-017-4085.
    PubMed     Text format     Abstract available


  228. WRIGHT NC, Foster PJ, Mudano AS, Melnick JA, et al
    Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.
    Osteoporos Int. 2017 May 24. doi: 10.1007/s00198-017-4073.
    PubMed     Text format     Abstract available


  229. UEBELHART B, Rizzoli R, Ferrari SL
    Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonates.
    Osteoporos Int. 2017 May 24. doi: 10.1007/s00198-017-4080.
    PubMed     Text format     Abstract available


  230. KESHISHIAN A, Boytsov N, Burge R, Krohn K, et al
    Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population.
    Osteoporos Int. 2017 May 23. doi: 10.1007/s00198-017-4072.
    PubMed     Text format     Abstract available


  231. LIN YC, Huang TS, Wu JS, Cheung YC, et al
    Are bilateral decubitus views necessary in assessing for vertebral compression fractures using DXA vertebral fracture assessment?
    Osteoporos Int. 2017 May 9. doi: 10.1007/s00198-017-4040.
    PubMed     Text format     Abstract available


  232. BOGL HP, Aspenberg P, Schilcher J
    Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Osteoporos Int. 2017 May 4. doi: 10.1007/s00198-017-4058.
    PubMed     Text format     Abstract available


  233. MALGO F, Hamdy NAT, Papapoulos SE, Appelman-Dijkstra NM, et al
    Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site.
    Osteoporos Int. 2017 May 2. doi: 10.1007/s00198-017-4054.
    PubMed     Text format     Abstract available


  234. LAIRD E, Molloy AM, McNulty H, Ward M, et al
    Greater yogurt consumption is associated with increased bone mineral density and physical function in older adults.
    Osteoporos Int. 2017 May 1. doi: 10.1007/s00198-017-4049.
    PubMed     Text format     Abstract available


  235. LEE JH, Kim JH, Hong AR, Kim SW, et al
    Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism.
    Osteoporos Int. 2017;28:1667-1674.
    PubMed     Text format     Abstract available


  236. ZHOU L, Song J, Yang S, Meng S, et al
    Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet: a retrospective cross-sectional study.
    Osteoporos Int. 2017;28:1693-1698.
    PubMed     Text format     Abstract available


  237. MCCLUNG MR, Wagman RB, Miller PD, Wang A, et al
    Observations following discontinuation of long-term denosumab therapy.
    Osteoporos Int. 2017;28:1723-1732.
    PubMed     Text format     Abstract available


    April 2017
  238. KANIS JA, Cooper C, Rizzoli R, Abrahamsen B, et al
    Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4009.
    PubMed     Text format     Abstract available


  239. HASEGAWA T, Kawakita A, Ueda N, Funahara R, et al
    A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRO
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4063.
    PubMed     Text format     Abstract available


  240. MCCLOSKEY EV
    Identification of vertebral fractures: a moderately severe solution?
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4042.
    PubMed     Text format    


  241. LI C, Zeng Y, Tao L, Liu S, et al
    Meta-analysis of hypertension and osteoporotic fracture risk in women and men.
    Osteoporos Int. 2017 Apr 26. doi: 10.1007/s00198-017-4050.
    PubMed     Text format     Abstract available


  242. CLARK EM, Cummings SR, Schousboe JT
    Spinal radiographs in those with back pain-when are they appropriate to diagnose vertebral fractures?
    Osteoporos Int. 2017 Apr 25. doi: 10.1007/s00198-017-4052.
    PubMed     Text format     Abstract available


  243. GUAN Y, Lv F, Meng Y, Ma D, et al
    Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study.
    Osteoporos Int. 2017 Apr 24. doi: 10.1007/s00198-017-4041.
    PubMed     Text format     Abstract available


  244. MOBERG L, Nilsson PM, Samsioe G, Sallsten G, et al
    Increased blood cadmium levels were not associated with increased fracture risk but with increased total mortality in women: the Malmo Diet and Cancer Study.
    Osteoporos Int. 2017 Apr 21. doi: 10.1007/s00198-017-4047.
    PubMed     Text format     Abstract available


  245. DOMBROWSKI S, Jacob L, Hadji P, Kostev K, et al
    Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4036.
    PubMed     Text format     Abstract available


  246. SATO H, Kondo N, Nakatsue T, Wada Y, et al
    High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4038.
    PubMed     Text format     Abstract available


  247. YAN J, Liu HJ, Li H, Chen L, et al
    Circulating periostin levels increase in association with bone density loss and healing progression during the early phase of hip fracture in Chinese older women.
    Osteoporos Int. 2017 Apr 5. doi: 10.1007/s00198-017-4034.
    PubMed     Text format     Abstract available


  248. RODRIGUEZ AJ, Scott D, Hodge A, English DR, et al
    Associations between hip bone mineral density, aortic calcification and cardiac workload in community-dwelling older Australians.
    Osteoporos Int. 2017 Apr 4. doi: 10.1007/s00198-017-4024.
    PubMed     Text format     Abstract available


    March 2017
  249. GALLI S, Stocchero M, Andersson M, Karlsson J, et al
    The effect of magnesium on early osseointegration in osteoporotic bone: a histological and gene expression investigation.
    Osteoporos Int. 2017 Mar 27. doi: 10.1007/s00198-017-4004.
    PubMed     Text format     Abstract available


  250. WU J, Xu L, Lv Y, Dong L, et al
    Quantitative analysis of efficacy and associated factors of calcium intake on bone mineral density in postmenopausal women.
    Osteoporos Int. 2017 Mar 23. doi: 10.1007/s00198-017-3993.
    PubMed     Text format     Abstract available


  251. CHEN YY, Feng JY, Ting WY, Yen YF, et al
    Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area.
    Osteoporos Int. 2017 Mar 22. doi: 10.1007/s00198-017-3939.
    PubMed     Text format     Abstract available


  252. MORIWAKI K, Mouri M, Hagino H
    Erratum to: Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.
    Osteoporos Int. 2017 Mar 21. doi: 10.1007/s00198-017-4006.
    PubMed     Text format    


  253. LAINE CM, Landin-Wilhelmsen K
    Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up.
    Osteoporos Int. 2017 Mar 21. doi: 10.1007/s00198-017-3981.
    PubMed     Text format     Abstract available


  254. THOMPSON MJ, Aitken DA, Otahal P, Cicolini J, et al
    The relationship between cumulative lifetime ultraviolet radiation exposure, bone mineral density, falls risk and fractures in older adults.
    Osteoporos Int. 2017 Mar 20. doi: 10.1007/s00198-017-4001.
    PubMed     Text format     Abstract available


  255. LOOKER AC, Sarafrazi Isfahani N, Fan B, Shepherd JA, et al
    Trends in osteoporosis and low bone mass in older US adults, 2005-2006 through 2013-2014.
    Osteoporos Int. 2017 Mar 18. doi: 10.1007/s00198-017-3996.
    PubMed     Text format     Abstract available


  256. MOHD-TAHIR NA, Li SC
    Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3985.
    PubMed     Text format     Abstract available


  257. ASADIPOOYA K, Graves L, Greene LW
    Transient osteoporosis of the hip: review of the literature.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3952.
    PubMed     Text format     Abstract available


  258. POPP AW, Senn R, Curkovic I, Senn C, et al
    Factors associated with acute-phase response of bisphosphonate-naive or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.
    Osteoporos Int. 2017 Mar 15. doi: 10.1007/s00198-017-3992.
    PubMed     Text format     Abstract available


  259. CHANG HK, Chang DG, Myong JP, Kim JH, et al
    Bone mineral density among Korean females aged 20-50 years: influence of age at menarche (The Korea National Health and Nutrition Examination Survey 2008-2011).
    Osteoporos Int. 2017 Mar 14. doi: 10.1007/s00198-017-3997.
    PubMed     Text format     Abstract available


  260. EASTELL R, Diez-Perez A
    Recommendations for the screening of adherence to oral bisphosphonates: reply to comments by Zhou and Sheng.
    Osteoporos Int. 2017 Mar 10. doi: 10.1007/s00198-017-3991.
    PubMed     Text format    


  261. ZHOU YH, Sheng ZF
    Comments on Diez-Perez et al.: Recommendations for the screening of adherence to oral bisphosphonates.
    Osteoporos Int. 2017 Mar 10. doi: 10.1007/s00198-017-3987.
    PubMed     Text format    


  262. MAJUMDAR SR, Lier DA, Hanley DA, Juby AG, et al
    Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Osteoporos Int. 2017 Mar 9. doi: 10.1007/s00198-017-3986.
    PubMed     Text format     Abstract available


  263. IMAI T, Tanaka S, Kawakami K, Miyazaki T, et al
    Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3966.
    PubMed     Text format     Abstract available


  264. MORIWAKI K, Mouri M, Hagino H
    Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3973.
    PubMed     Text format     Abstract available


  265. KERR C, Bottomley C, Shingler S, Giangregorio L, et al
    The importance of physical function to people with osteoporosis.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3911.
    PubMed     Text format     Abstract available


  266. HAN MH, Ryu JI, Kim CH, Kim JM, et al
    Influence of systemic bone mineral density on atlantoaxial subluxation in patients with rheumatoid arthritis.
    Osteoporos Int. 2017 Mar 2. doi: 10.1007/s00198-017-3972.
    PubMed     Text format     Abstract available


  267. WEI Y, Tian W, Zhang GL, Lv YW, et al
    Thoracolumbar kyphosis is associated with compressive vertebral fracture in postmenopausal women.
    Osteoporos Int. 2017 Mar 1. doi: 10.1007/s00198-017-3971.
    PubMed     Text format     Abstract available


    February 2017
  268. MERLE B, Chapurlat R, Vignot E, Thomas T, et al
    Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial.
    Osteoporos Int. 2017 Feb 28. doi: 10.1007/s00198-017-3953.
    PubMed     Text format     Abstract available


  269. TAMAKI J, Iki M, Sato Y, Kajita E, et al
    Total 25-hydroxyvitamin D levels predict fracture risk: results from the 15-year follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Osteoporos Int. 2017 Feb 27. doi: 10.1007/s00198-017-3967.
    PubMed     Text format     Abstract available


  270. DU Y, Zhao LJ, Xu Q, Wu KH, et al
    Socioeconomic status and bone mineral density in adults by race/ethnicity and gender: the Louisiana osteoporosis study.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3951.
    PubMed     Text format     Abstract available


  271. MORFELD JC, Vennedey V, Muller D, Pieper D, et al
    Patient education in osteoporosis prevention: a systematic review focusing on methodological quality of randomised controlled trials.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3946.
    PubMed     Text format     Abstract available


  272. ROUX C, Briot K
    Imminent fracture risk.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3976.
    PubMed     Text format     Abstract available


  273. LEE SH, Hsu WT, Lai CC, Esmaily-Fard A, et al
    Erratum to: Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Feb 23. doi: 10.1007/s00198-017-3938.
    PubMed     Text format    


  274. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.
    Osteoporos Int. 2017 Feb 17. doi: 10.1007/s00198-017-3940.
    PubMed     Text format     Abstract available


  275. MARQUES ID, Araujo MJ, Graciolli FG, Reis LM, et al
    Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities.
    Osteoporos Int. 2017 Feb 16. doi: 10.1007/s00198-017-3956.
    PubMed     Text format     Abstract available


  276. COLARES NETO GP, Pereira RM, Alvarenga JC, Takayama L, et al
    Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets.
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3949.
    PubMed     Text format     Abstract available


  277. DEDE AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, et al
    Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3927.
    PubMed     Text format    


  278. MORTON A
    A role for thiazide diuretic therapy in preventing bone loss, fracture, and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3922.
    PubMed     Text format    


  279. LEE DY, Jee JH, Cho YY, Jang JY, et al
    Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis.
    Osteoporos Int. 2017 Feb 10. doi: 10.1007/s00198-016-3892.
    PubMed     Text format     Abstract available


  280. HARVEY NC, McCloskey EV, Mitchell PJ, Dawson-Hughes B, et al
    Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.
    Osteoporos Int. 2017 Feb 7. doi: 10.1007/s00198-016-3894.
    PubMed     Text format     Abstract available


  281. BALLANE G, Cauley JA, Luckey MM, El-Hajj Fuleihan G, et al
    Worldwide prevalence and incidence of osteoporotic vertebral fractures.
    Osteoporos Int. 2017 Feb 6. doi: 10.1007/s00198-017-3909.
    PubMed     Text format     Abstract available


  282. LESPESSAILLES E, Cortet B, Legrand E, Guggenbuhl P, et al
    Low-trauma fractures without osteoporosis.
    Osteoporos Int. 2017 Feb 4. doi: 10.1007/s00198-017-3921.
    PubMed     Text format     Abstract available


  283. MIKULA AL, Hetzel SJ, Binkley N, Anderson PA, et al
    Validity of height loss as a predictor for prevalent vertebral fractures, low bone mineral density, and vitamin D deficiency.
    Osteoporos Int. 2017 Feb 3. doi: 10.1007/s00198-017-3937.
    PubMed     Text format     Abstract available


    January 2017
  284. FU SJ, Sheng ZF
    Comments on Kamimura et al.: significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.
    Osteoporos Int. 2017 Jan 27. doi: 10.1007/s00198-016-3867.
    PubMed     Text format    


  285. KAMIMURA M, Nakamura Y, Ikegami S, Uchiyama S, et al
    Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments.
    Osteoporos Int. 2017 Jan 27. doi: 10.1007/s00198-017-3923.
    PubMed     Text format    


  286. OKUBO R, Sanada LS, Castania VA, Louzada MJ, et al
    Jumping exercise preserves bone mineral density and mechanical properties in osteopenic ovariectomized rats even following established osteopenia.
    Osteoporos Int. 2017 Jan 26. doi: 10.1007/s00198-017-3905.
    PubMed     Text format     Abstract available


  287. ALACREU E, Moratal D, Arana E
    Opportunistic screening for osteoporosis by routine CT in Southern Europe.
    Osteoporos Int. 2017 Jan 20. doi: 10.1007/s00198-016-3804.
    PubMed     Text format     Abstract available


  288. DIEZ-PEREZ A, Naylor KE, Abrahamsen B, Agnusdei D, et al
    International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.
    Osteoporos Int. 2017 Jan 16. doi: 10.1007/s00198-017-3906.
    PubMed     Text format     Abstract available


  289. HONG AR, Kim JH, Lee KH, Kim TY, et al
    Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3899.
    PubMed     Text format     Abstract available


  290. LIM Y, Jo K, Ha HS, Yim HW, et al
    The prevalence of osteoporosis and the rate of bone loss in Korean adults: the Chungju metabolic disease cohort (CMC) study.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3893.
    PubMed     Text format     Abstract available


  291. LEE SH, Hsu WT, Lai CC, Amin EF, et al
    Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3881.
    PubMed     Text format     Abstract available


  292. HADJI P, Boekhoff J, Hahn M, Hellmeyer L, et al
    Pregnancy-associated osteoporosis: a case-control study.
    Osteoporos Int. 2017 Jan 10. doi: 10.1007/s00198-016-3897.
    PubMed     Text format     Abstract available


  293. MODI A, Sajjan S, Insinga R, Weaver J, et al
    Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years.
    Osteoporos Int. 2017 Jan 5. doi: 10.1007/s00198-016-3886.
    PubMed     Text format     Abstract available


    December 2016
  294. JOHANSSON H, Siggeirsdottir K, Harvey NC, Oden A, et al
    Imminent risk of fracture after fracture.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3868.
    PubMed     Text format     Abstract available


  295. BURGE RT, Disch DP, Gelwicks S, Zhang X, et al
    Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3888.
    PubMed     Text format     Abstract available


  296. FAHRLEITNER-PAMMER A, Wagner D, Krisper P, Amrein K, et al
    Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  297. MANA DL, Zanchetta MB, Zanchetta JR
    Retreatment with teriparatide: our experience in three patients with severe secondary osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  298. WRIGHT NC, Saag KG, Dawson-Hughes B, Khosla S, et al
    The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  299. FECHTENBAUM J, Kolta S, Briot K, Roux C, et al
    Vertebral fracture assessment by dual X-ray absorptiometry.
    Osteoporos Int. 2016.
    PubMed     Text format    


  300. RUD B, Hyldstrup L
    Vertebral fracture assessment by dual X-ray absorptiometry: reply to comments by Fechtenbaum et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  301. JUHASZ B, Gulyas K, Horvath A, Petho Z, et al
    Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  302. OTA M, Takahata M, Shimizu T, Kanehira Y, et al
    Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  303. CHEN GD, Ding D, Tian HY, Zhu YY, et al
    Adherence to the 2006 American Heart Association's Diet and Lifestyle Recommendations for cardiovascular disease risk reduction is associated with bone mineral density in older Chinese.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  304. ABDERHALDEN L, Weaver FM, Bethel M, Demirtas H, et al
    Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  305. CORREA CB, Camargos GV, Chatterjee M, Mesquita MF, et al
    Can the alendronate dosage be altered when combined with high-frequency loading in osteoporosis treatment?
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  306. CIRNIGLIARO CM, Myslinski MJ, La Fountaine MF, Kirshblum SC, et al
    Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  307. JAMAL SA, Reid LS, Hamilton CJ
    Statement of concern re: The effects of organic nitrates on osteoporosis: a systematic review.
    Osteoporos Int. 2016.
    PubMed     Text format    


  308. JAMAL SA, Goltzman D, Hanley DA, Papaioannou A, et al
    Retraction to: Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  309. ZHANG J, Hu X, Zhang J
    Associations between serum vitamin E concentration and bone mineral density in the US elderly population.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  310. DIVASTA AD, Feldman HA, Rubin CT, Gallagher JS, et al
    The ability of low-magnitude mechanical signals to normalize bone turnover in adolescents hospitalized for anorexia nervosa.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    November 2016
  311. MAWATARI T, Muraoka R, Iwamoto Y
    Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  312. NOGUCHI T, Ebina K, Hirao M, Morimoto T, et al
    Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  313. AN T, Hao J, Sun S, Li R, et al
    Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  314. JACOB L, Kostev K
    Impact of attention deficit hyperactivity disorder therapy on fracture risk in children treated in German pediatric practices.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  315. YOSHIMURA N, Muraki S, Oka H, Iidaka T, et al
    Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  316. SANCHEZ A, Blanco R
    Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  317. KIM H, Baek KH, Lee SY, Ahn SH, et al
    Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  318. KRUSE C, Eiken P, Vestergaard P
    Clinical fracture risk evaluated by hierarchical agglomerative clustering.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  319. ZHU W, Shen H, Zhang JG, Zhang L, et al
    Cytosolic proteome profiling of monocytes for male osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  320. RAY R, Clement ND, Aitken SA, McQueen MM, et al
    High mortality in younger patients with major osteoporotic fractures.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  321. GARCIA-HOYOS M, Garcia-Unzueta MT, de Luis D, Valero C, et al
    Diverging results of areal and volumetric bone mineral density in Down syndrome.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  322. MATHAVAN N, Tagil M, Isaksson H
    Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractures in an open fracture osteoporotic rat model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  323. SHAH A, Prieto-Alhambra D, Hawley S, Delmestri A, et al
    Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available



  324. ABSTRACTS OF OSTEOPOROSIS CONFERENCE 2016.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  325. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Author index.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  326. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Plenary Lectures.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  327. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Oral Communications.
    Osteoporos Int. 2016;27.
    PubMed     Text format    



  328. IOF Regionals - 6th Asia-Pacific Osteoporosis Meeting : Poster Presentations.
    Osteoporos Int. 2016;27.
    PubMed     Text format    


    October 2016
  329. ZERBINI CA, Clark P, Mendez-Sanchez L, Pereira RM, et al
    Biologic therapies and bone loss in rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  330. BEATON DE, Vidmar M, Pitzul KB, Sujic R, et al
    Addition of a fracture risk assessment to a coordinator's role improved treatment rates within 6 months of screening in a fragility fracture screening program.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  331. BELHASSEN M, Confavreux CB, Cortet B, Lamezec L, et al
    Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  332. FINK HA, Litwack-Harrison S, Taylor BC, Bauer DC, et al
    Erratum to: Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the osteoporotic fractures in men (MrOS) study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  333. HARVEY NC, Biver E, Kaufman JM, Bauer J, et al
    The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Fo
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  334. TSENTIDIS C, Gourgiotis D, Kossiva L, Marmarinos A, et al
    Increased levels of Dickkopf-1 are indicative of Wnt/beta-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  335. IKI M, Fujita Y, Tamaki J, Kouda K, et al
    Incident fracture associated with increased risk of mortality even after adjusting for frailty status in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  336. HILIGSMANN M, Burlet N, Fardellone P, Al-Daghri N, et al
    Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  337. CHOI HS, Park JH, Kim SH, Shin S, et al
    Strong familial association of bone mineral density between parents and offspring: KNHANES 2008-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  338. YOSHIMURA M, Moriwaki K, Noto S, Takiguchi T, et al
    A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  339. FARMER S, Shanbhogue VV, Hansen S, Stahlberg CI, et al
    Bone mineral density and microarchitecture in patients with essential thrombocythemia and polycythemia vera.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  340. SU Y, Leung J, Hans D, Aubry-Rozier B, et al
    Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  341. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  342. PIRRO M, Mannarino MR, Bianconi V, De Vuono S, et al
    Uric acid and bone mineral density in postmenopausal osteoporotic women: the link lies within the fat.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  343. WALLACE ER, Siscovick DS, Sitlani CM, Dublin S, et al
    Incident atrial fibrillation and the risk of fracture in the cardiovascular health study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  344. RODRIGUES IB, Armstrong JJ, Adachi JD, MacDermid JC, et al
    Facilitators and barriers to exercise adherence in patients with osteopenia and osteoporosis: a systematic review.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  345. KAMYCHEVA E, Goto T, Camargo CA Jr
    Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  346. MORIWAKI K, Noto S
    Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    September 2016
  347. ATTERITANO M, Di Mauro E, Canale V, Bruzzese AM, et al
    Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  348. CHEN J, Smerdely P
    Hypocalcaemia after denosumab in older people following fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  349. XU MH, Li X, Yuan FL
    Is it necessary to investigate rapamycin-modulated autophagy during the development of experimental osteoporosis in female rat?
    Osteoporos Int. 2016.
    PubMed     Text format    


  350. CHAKHTOURA M, Leslie WD, McClung M, Cheung AM, et al
    The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  351. KAMIMURA M, Nakamura Y, Ikegami S, Uchiyama S, et al
    Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  352. AVENELL A, Bolland MJ, Grey A, Reid IR, et al
    Further major uncorrected errors in National Osteoporosis Foundation meta-analyses of calcium and vitamin D supplementation in fracture prevention.
    Osteoporos Int. 2016.
    PubMed     Text format    


  353. SMALLWOOD AJ, Schapira MM, Fedders M, Neuner JM, et al
    A pilot randomized controlled trial of a decision aid with tailored fracture risk tool delivered via a patient portal.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  354. WU X, Wei D, Sun B, Wu XN, et al
    Poor medication adherence to bisphosphonates and high self-perception of aging in elderly female patients with osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  355. BALOGH R, Wood J, Dobranowski K, Lin E, et al
    Low-trauma fractures and bone mineral density testing in adults with and without intellectual and developmental disabilities: a population study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  356. NAKAMURA T, Fukunaga M, Nakano T, Kishimoto H, et al
    Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  357. CATALANO A, Vita GL, Russo M, Vita G, et al
    Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  358. AUBRY-ROZIER B, Fabreguet I, Iglesias K, Lamy O, et al
    Impact of level of expertise versus the statistical tool on vertebral fracture assessment (VFA) readings in cohort studies.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  359. PEREIRA L, Bliuc D, Stanford P, Eisman JA, et al
    More-than-minimal-trauma fractures are associated with low bone density: an 8-year prospective study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    August 2016
  360. NI W, Jiang Y
    Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  361. TAKAHASHI S, Hoshino M, Takayama K, Iseki K, et al
    Time course of osteoporotic vertebral fractures by magnetic resonance imaging using a simple classification: a multicenter prospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  362. DUAN X, Wang J, Jiang X
    A meta-analysis of breastfeeding and osteoporotic fracture risk in the females.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  363. SU Y, Leung J, Hans D, Lamy O, et al
    The added value of trabecular bone score to FRAX(R) to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  364. BUCHELE G, Becker C, Cameron ID, Auer R, et al
    Fracture risk in people with developmental disabilities: results of a large claims data analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  365. POP LC, Sukumar D, Schneider SH, Schlussel Y, et al
    Three doses of vitamin D, bone mineral density, and geometry in older women during modest weight control in a 1-year randomized controlled trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  366. LU PC, Yang YH, Guo SE, Yang TM, et al
    Factors associated with osteoporosis in patients with chronic obstructive pulmonary disease-a nationwide retrospective study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  367. HWANG J, Lee EK, Ahn JK, Cha HS, et al
    Bone-density testing interval and transition to osteoporosis in patients with rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  368. DEDE AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, et al
    Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  369. CLARK E
    Health-related quality of life in older people with osteoporotic vertebral fractures: response to comments by Sani et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  370. SANI M, Ayubi E, Khazaei S, Mansori K, et al
    Health-related quality of life in older people with osteoporotic vertebral fractures: clinically important vs. statistically significant.
    Osteoporos Int. 2016.
    PubMed     Text format    


  371. KIM MK, Chon SJ, Noe EB, Roh YH, et al
    Associations of dietary calcium intake with metabolic syndrome and bone mineral density among the Korean population: KNHANES 2008-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  372. SCHOUSBOE JT, Riekkinen O, Karjalainen J
    Prediction of hip osteoporosis by DXA using a novel pulse-echo ultrasound device.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  373. KIM YW, Kim JH, Yoon SH, Lee JH, et al
    Vertebral bone attenuation on low-dose chest CT: quantitative volumetric analysis for bone fragility assessment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    July 2016
  374. HANSEN L, Petersen KD, Eriksen SA, Gerstoft F, et al
    Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  375. ZHU K, Hunter M, James A, Lim EM, et al
    Discordance between fat mass index and body mass index is associated with reduced bone mineral density in women but not in men: the Busselton Healthy Ageing Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  376. LO JC, Kim S, Chandra M, Ettinger B, et al
    Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  377. GAO C, Qiao J, Li SS, Yu WJ, et al
    The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  378. KYVERNITAKIS I, Kostev K, Nassour T, Thomasius F, et al
    The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  379. BURR DB
    The use of finite element analysis to estimate the changing strength of bone following treatment for osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format    


  380. WARD J, Wood C, Rouch K, Pienkowski D, et al
    Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  381. MCCLOSKEY EV, Johansson H, Harvey NC, Compston J, et al
    Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  382. QIN W, Zhao W, Li X, Peng Y, et al
    Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  383. LEWIECKI EM, Boyle JF, Arora S, Bouchonville MF 2nd, et al
    Telementoring: a novel approach to reducing the osteoporosis treatment gap.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  384. WOZNIAK LA, Johnson JA, McAlister FA, Beaupre LA, et al
    Understanding fragility fracture patients' decision-making process regarding bisphosphonate treatment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  385. MORSE LR, Nguyen N, Battaglino RA, Guarino AJ, et al
    Wheelchair use and lipophilic statin medications may influence bone loss in chronic spinal cord injury: findings from the FRASCI-bone loss study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  386. MORAN JM, Pedrera-Zamorano JD
    Comments on: The effect of prolonged breast-feeding on the development of postmenopausal osteoporosis in population with insufficient calcium intake and vitamin D level.
    Osteoporos Int. 2016.
    PubMed     Text format    


  387. YUN BH, Seo SK
    Response to comments by Moran et al. on: The effect of prolonged breast-feeding on the development of postmenopausal osteoporosis in population with insufficient calcium intake and vitamin D level.
    Osteoporos Int. 2016.
    PubMed     Text format    


  388. WEAVER CM, Dawson-Hughes B, Lappe JM, Wallace TC, et al
    Erratum and additional analyses re: Calcium plus vitamin D supplementation and the risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
    Osteoporos Int. 2016.
    PubMed     Text format    


  389. KJELLBERG J, Jorgensen AD, Vestergaard P, Ibsen R, et al
    Cost and health care resource use associated with noncompliance with oral bisphosphonate therapy: an analysis using Danish health registries.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  390. UGURLAR M
    Alendronate- and risedronate-induced acute polyarthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  391. SENAY A, Delisle J, Giroux M, Laflamme GY, et al
    The impact of a standardized order set for the management of non-hip fragility fractures in a Fracture Liaison Service.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    June 2016
  392. LOU Y, Edmonds SW, Jones MP, Ullrich F, et al
    Predictors of bone mineral density testing among older women on Medicare.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  393. CHANG PY, Saechao FS, Lee J, Haskell SG, et al
    Prevalence and risk of fracture diagnoses in women across the adult life span: a national cross-sectional study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  394. TAKAHASHI S, Hoshino M, Takayama K, Iseki K, et al
    Predicting delayed union in osteoporotic vertebral fractures with consecutive magnetic resonance imaging in the acute phase: a multicenter cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  395. AKTAS I, Nazikoglu C, Kepez A, Ozkan FU, et al
    Effect of intravenous zoledronic acid infusion on electrocardiographic parameters in patients with osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  396. KARAYIANNIS PN, McAlinden MG
    Falling age-related incidence of hip fractures in women, but not men, in Northern Ireland: 2001-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  397. MARQUES EA, Gudnason V, Lang T, Sigurdsson G, et al
    Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women: the AGES-Reykjavik longitudinal study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  398. YAGI M, Ohne H, Konomi T, Fujiyoshi K, et al
    Teriparatide improves volumetric bone mineral density and fine bone structure in the UIV+1 vertebra, and reduces bone failure type PJK after surgery for adult spinal deformity.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  399. PEI YF, Xie ZG, Wang XY, Hu WZ, et al
    Association of 3q13.32 variants with hip trochanter and intertrochanter bone mineral density identified by a genome-wide association study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  400. PEREIRA RM, Figueiredo CP, Cha CC, Caparbo VF, et al
    Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  401. LUCATO P, Trevisan C, Stubbs B, Zanforlini BM, et al
    Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  402. BALASUBRAMANIAN A, Wade SW, Adler RA, Lin CJ, et al
    Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  403. ZHOU J, Ma X, Wang T, Zhai S, et al
    Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  404. AL-SARI UA, Tobias J, Clark E
    Health-related quality of life in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  405. YEH CB, Weng SJ, Chang KW, Chan JY, et al
    Calcitonin alleviates hyperalgesia in osteoporotic rats by modulating serotonin transporter activity.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  406. BARZILAY JI, Buzkova P, Fink HA, Cauley JA, et al
    Systemic markers of microvascular disease and bone mineral density in older adults : The cardiovascular health study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    May 2016
  407. ZHAO Y, Xue R, Shi N, Xue Y, et al
    Aggravation of spinal cord compromise following new osteoporotic vertebral compression fracture prevented by teriparatide in patients with surgical contraindications.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  408. SHIRAKI M, Ueda S, Sugimoto T, Kuroda T, et al
    Treatment responses with once-weekly teriparatide therapy for osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  409. KONAK HE, Kibar S, Ergin ES
    The effect of single-task and dual-task balance exercise programs on balance performance in adults with osteoporosis: a randomized controlled preliminary trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  410. BETHEL M, Weaver FM, Bailey L, Miskevics S, et al
    Risk factors for osteoporotic fractures in persons with spinal cord injuries and disorders.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  411. AXELSSON KF, Jacobsson R, Lund D, Lorentzon M, et al
    Effectiveness of a minimal resource fracture liaison service.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  412. DENOVA-GUTIERREZ E, Clark P, Tucker KL, Munoz-Aguirre P, et al
    Dietary patterns are associated with bone mineral density in an urban Mexican adult population.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  413. WALKER MD, Saeed I, Lee JA, Zhang C, et al
    Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  414. SHIPMAN KE, Stammers J, Doyle A, Gittoes N, et al
    Delivering a quality-assured fracture liaison service in a UK teaching hospital-is it achievable?
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  415. IWANIEC UT, Philbrick KA, Wong CP, Gordon JL, et al
    Room temperature housing results in premature cancellous bone loss in growing female mice: implications for the mouse as a preclinical model for age-related bone loss.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  416. CHUNG SM, Hyun MH, Lee E, Seo HS, et al
    Novel effects of sarcopenic osteoarthritis on metabolic syndrome, insulin resistance, osteoporosis, and bone fracture: the national survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  417. HADJI P, Kyvernitakis I, Kann PH, Niedhart C, et al
    GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  418. HOPKINS RB, Burke N, Von Keyserlingk C, Leslie WD, et al
    The current economic burden of illness of osteoporosis in Canada.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  419. CUNNINGHAM TD, Martin BC, DeShields SC, Romero CC, et al
    The impact of osteoporotic fractures compared with other health conditions in older adults living in Virginia, United States.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  420. PENTON H, Hiligsmann M, Harrison M, Reginster JY, et al
    Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  421. CHOW SK, Leung KS, Qin J, Guo A, et al
    Mechanical stimulation enhanced estrogen receptor expression and callus formation in diaphyseal long bone fracture healing in ovariectomy-induced osteoporotic rats.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  422. SOLTANI S, Hunter GR, Kazemi A, Shab-Bidar S, et al
    The effects of weight loss approaches on bone mineral density in adults: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  423. OLIVEIRA LC, Oliveira RG, Pires-Oliveira DA
    Effects of whole body vibration on bone mineral density in postmenopausal women: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  424. YANG TC, Duthie GG, Aucott LS, Macdonald HM, et al
    Vitamin E homologues alpha- and gamma-tocopherol are not associated with bone turnover markers or bone mineral density in peri-menopausal and post-menopausal women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  425. MCCLUNG MR
    Cancel the denosumab holiday.
    Osteoporos Int. 2016;27:1677-82.
    PubMed     Text format    


  426. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Usefulness of daily teriparatide treatment in elderly patients over 80 years of age.
    Osteoporos Int. 2016;27:1869-74.
    PubMed     Text format     Abstract available


  427. PAUPITZ JA, Lima GL, Alvarenga JC, Oliveira RM, et al
    Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus.
    Osteoporos Int. 2016;27:1839-48.
    PubMed     Text format     Abstract available


    April 2016
  428. METZGER CE, Baek K, Swift SN, De Souza MJ, et al
    Exercise during energy restriction mitigates bone loss but not alterations in estrogen status or metabolic hormones.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  429. WARD LM, Konji VN, Ma J
    The management of osteoporosis in children.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  430. ZHAO G, Liu X, Li F
    Balloon kyphoplasty versus percutaneous vertebroplasty for treatment of osteoporotic vertebral compression fractures (OVCFs).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  431. BEAUDOIN C, Jean S, Bessette L, Ste-Marie LG, et al
    Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  432. SILVERMAN SL, Kupperman ES, Bukata SV
    Fracture healing: a consensus report from the International Osteoporosis Foundation Fracture Working Group.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  433. KIM YM, Kim SH, Kim S, Yoo JS, et al
    Variations in fat mass contribution to bone mineral density by gender, age, and body mass index: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  434. LESLIE WD, Majumdar SR, Lix LM, Josse RG, et al
    Direct comparison of FRAX and a simplified fracture risk assessment tool in routine clinical practice: a registry-based cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  435. WANG FS, Lian WS, Weng WT, Sun YC, et al
    Neuropeptide Y mediates glucocorticoid-induced osteoporosis and marrow adiposity in mice.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  436. YUN BH, Chon SJ, Choi YS, Cho S, et al
    The effect of prolonged breast-feeding on the development of postmenopausal osteoporosis in population with insufficient calcium intake and vitamin D level.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  437. HILIGSMANN M, Ronda G, van der Weijden T, Boonen A, et al
    The development of a personalized patient education tool for decision making for postmenopausal women with osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available



  438. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Committee of National Societies Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:579-84.
    PubMed     Text format    



  439. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Non-sponsored Symposia Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:555-77.
    PubMed     Text format    



  440. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Satellite Symposia Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:549-53.
    PubMed     Text format    



  441. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Poster Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:79-548.
    PubMed     Text format    



  442. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Meet-the-Expert Sessions.
    Osteoporos Int. 2016;27 Suppl 1:71-8.
    PubMed     Text format    



  443. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Educational Lecture Abstract.
    Osteoporos Int. 2016;27 Suppl 1:69.
    PubMed     Text format    



  444. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): ESCEO Symposia Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:63-8.
    PubMed     Text format    



  445. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Oral Communication Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:39-62.
    PubMed     Text format    



  446. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Plenary Lecture Abstracts.
    Osteoporos Int. 2016;27 Suppl 1:33-7.
    PubMed     Text format    



  447. WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
    Osteoporos Int. 2016;27 Suppl 1:1-32.
    PubMed     Text format    


  448. TSENTIDIS C, Gourgiotis D, Kossiva L, Doulgeraki A, et al
    Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Osteoporos Int. 2016;27:1631-43.
    PubMed     Text format     Abstract available


  449. HOFFMAN V, Xue F, Gardstein B, Skerry K, et al
    Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data.
    Osteoporos Int. 2016;27:1653-8.
    PubMed     Text format     Abstract available


  450. JACQUOT J, Delion M, Gangloff S, Braux J, et al
    Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.
    Osteoporos Int. 2016;27:1401-12.
    PubMed     Text format     Abstract available


    March 2016
  451. DROSSELMEYER J, Rapp MA, Hadji P, Kostev K, et al
    Depression risk in female patients with osteoporosis in primary care practices in Germany.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  452. CAVALIER E, Bergmann P, Bruyere O, Delanaye P, et al
    The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  453. BHAVSAR NV, Trivedi SR, Dulani K, Brahmbhatt N, et al
    Clinical and radiographic evaluation of effect of risedronate 5 mg as an adjunct to treatment of chronic periodontitis in postmenopausal women (12-month study).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  454. FROST SA, Nguyen TV
    Uncertain effects of calcium and vitamin D supplementation on fracture risk reduction.
    Osteoporos Int. 2016.
    PubMed     Text format    


  455. EVSTIGNEEVA L, Lesnyak O, Bultink IE, Lems WF, et al
    Effect of twelve-month physical exercise program on patients with osteoporotic vertebral fractures: a randomized, controlled trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  456. PERRY BA, Archer KR, Song Y, Ma Y, et al
    Erratum to: Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  457. BAE SJ, Lee SH, Ahn SH, Kim HM, et al
    The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  458. ROUX JP, Belghali S, Wegrzyn J, Rendu ES, et al
    Vertebral body morphology is associated with incident lumbar vertebral fracture in postmenopausal women. The OFELY study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  459. LOOKER AC, Sarafrazi Isfahani N, Fan B, Shepherd JA, et al
    Trabecular bone scores and lumbar spine bone mineral density of US adults: comparison of relationships with demographic and body size variables.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  460. WEAVER CM, Gordon CM, Janz KF, Kalkwarf HJ, et al
    Erratum to: The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.
    Osteoporos Int. 2016.
    PubMed     Text format    


  461. BUCKINX F, Reginster JY, Cavalier E, Petermans J, et al
    Determinants of vitamin D supplementation prescription in nursing homes: a survey among general practitioners.
    Osteoporos Int. 2016;27:881-6.
    PubMed     Text format     Abstract available


  462. MOSTI MP, Flemmen G, Hoff J, Stunes AK, et al
    Impaired skeletal health and neuromuscular function among amphetamine users in clinical treatment.
    Osteoporos Int. 2016;27:1003-10.
    PubMed     Text format     Abstract available


  463. ZHANG Y, Wang L, Song Y, Zhao X, et al
    Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.
    Osteoporos Int. 2016;27:1083-92.
    PubMed     Text format     Abstract available


  464. DAMIAN LO, Simon SP, Filipescu I, Bocsa C, et al
    Capillaroscopic findings in a case of Hajdu-Cheney syndrome.
    Osteoporos Int. 2016;27:1269-73.
    PubMed     Text format     Abstract available


  465. DUDLEY-JAVOROSKI S, Petrie MA, McHenry CL, Amelon RE, et al
    Bone architecture adaptations after spinal cord injury: impact of long-term vibration of a constrained lower limb.
    Osteoporos Int. 2016;27:1149-60.
    PubMed     Text format     Abstract available


    February 2016
  466. PERRY BA, Archer KR, Song Y, Ma Y, et al
    Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  467. HOPKINS SJ, Toms AD, Brown M, Welsman JR, et al
    A study investigating short- and medium-term effects on function, bone mineral density and lean tissue mass post-total knee replacement in a Caucasian female post-menopausal population: implications for hip fracture risk.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  468. LINDSAY R, Krege JH, Marin F, Jin L, et al
    Teriparatide for osteoporosis: importance of the full course.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  469. EL-HAJ M, Gurt I, Cohen-Kfir E, Dixit V, et al
    Reduced Sirtuin1 expression at the femoral neck in women who sustained an osteoporotic hip fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  470. ROSSINI M, Zanotti R, Orsolini G, Tripi G, et al
    Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  471. DELESKOG L, Laursen NO, Nielsen BR, Schwarz P, et al
    Vertebral fracture assessment by DXA is inferior to X-ray in clinical severe osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  472. LIM Y, Chun S, Lee JH, Baek KH, et al
    Association of bone mineral density and diabetic retinopathy in diabetic subjects: the 2008-2011 Korea National Health and Nutrition Examination Survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  473. RIZZOLI R, Benhamou CL, Halse J, Miller PD, et al
    Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  474. CHEN CH, Lin CL, Kao CH
    Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  475. WEAVER CM, Gordon CM, Janz KF, Kalkwarf HJ, et al
    The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  476. NORIEGA DC, Ramajo RH, Lite IS, Toribio B, et al
    Safety and clinical performance of kyphoplasty and SpineJack procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  477. BRUNETTI G, Papadia F, Tummolo A, Fischetto R, et al
    Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-alpha.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  478. LLOYD JT, Alley DE, Hochberg MC, Waldstein SR, et al
    Changes in bone mineral density over time by body mass index in the health ABC study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  479. GUARINO M, Loperto I, Camera S, Cossiga V, et al
    Osteoporosis across chronic liver disease.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  480. DRIESSEN JH, Hansen L, Eriksen SA, van Onzenoort HA, et al
    The epidemiology of fractures in Denmark in 2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  481. LAM FM, Bui M, Yang FZ, Pang MY, et al
    Chronic effects of stroke on hip bone density and tibial morphology: a longitudinal study.
    Osteoporos Int. 2016;27:591-603.
    PubMed     Text format     Abstract available


  482. VIAENE L, Behets GJ, Heye S, Claes K, et al
    Inflammation and the bone-vascular axis in end-stage renal disease.
    Osteoporos Int. 2016;27:489-97.
    PubMed     Text format     Abstract available


  483. HWANGBO Y, Kim JH, Kim SW, Park YJ, et al
    High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.
    Osteoporos Int. 2016;27:457-62.
    PubMed     Text format     Abstract available


  484. KAWALILAK CE, Johnston JD, Cooper DM, Olszynski WP, et al
    Role of endocortical contouring methods on precision of HR-pQCT-derived cortical micro-architecture in postmenopausal women and young adults.
    Osteoporos Int. 2016;27:789-96.
    PubMed     Text format     Abstract available


  485. KHEIR V, Munier FL, Aubry-Rozier B, Schorderet DF, et al
    Potential blindness in children of patients with hereditary bone disease.
    Osteoporos Int. 2016;27:841-4.
    PubMed     Text format     Abstract available


  486. TAN J, Fu X, Sun CG, Liu C, et al
    A single CT-guided percutaneous intraosseous injection of thermosensitive simvastatin/poloxamer 407 hydrogel enhances vertebral bone formation in ovariectomized minipigs.
    Osteoporos Int. 2016;27:757-67.
    PubMed     Text format     Abstract available


    January 2016
  487. SI L, Winzenberg TM, Chen M, Jiang Q, et al
    Screening for osteoporosis in Chinese post-menopausal women: a health economic modelling study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  488. DOU C, Chen Y, Ding N, Li N, et al
    Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  489. PEDERSEN AB, Baggesen LM, Ehrenstein V, Pedersen L, et al
    Perceived stress and risk of any osteoporotic fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  490. MUSUMECI M, Palermo A, D'Onofrio L, Vadala G, et al
    Erratum to: Serum chitotriosidase in postmenopausal women with severe osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format    


  491. AMICHE MA, Albaum JM, Tadrous M, Pechlivanoglou P, et al
    Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  492. KATZMAN WB, Vittinghoff E, Kado DM, Lane NE, et al
    Thoracic kyphosis and rate of incident vertebral fractures: the Fracture Intervention Trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  493. LEE JH, Lee YK, Oh SH, Ahn J, et al
    A systematic review of diagnostic accuracy of vertebral fracture assessment (VFA) in postmenopausal women and elderly men.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  494. DREW S, Judge A, Cooper C, Javaid MK, et al
    Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  495. WANG X, Yan S, Liu C, Xu Y, et al
    Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  496. ZHANG ZQ, Cao WT, Liu J, Cao Y, et al
    Greater serum carotenoid concentration associated with higher bone mineral density in Chinese adults.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  497. ZHENG Y, Wang C, Zhang H, Shao C, et al
    Polymorphisms in Wnt signaling pathway genes are associated with peak bone mineral density, lean mass, and fat mass in Chinese male nuclear families.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  498. WANG J, Yao M, Xu JH, Shu B, et al
    Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  499. LI M, Lv F, Zhang Z, Deng W, et al
    Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  500. LESLIE WD, Schousboe JT, Lix LM
    Towards better use of the net reclassification improvement (NRI) index.
    Osteoporos Int. 2016;27:411-2.
    PubMed     Text format    


  501. NAYLOR KE, Jacques RM, Paggiosi M, Gossiel F, et al
    Bone turnover markers: response to comments by Seeman and Nguyen.
    Osteoporos Int. 2016;27:37.
    PubMed     Text format    


  502. LEIB ES, Winzenrieth R
    Bone status in glucocorticoid-treated men and women.
    Osteoporos Int. 2016;27:39-48.
    PubMed     Text format     Abstract available


  503. MATUTE-LLORENTE A, Gonzalez-Aguero A, Gomez-Cabello A, Tous-Fajardo J, et al
    Effect of whole-body vibration training on bone mass in adolescents with and without Down syndrome: a randomized controlled trial.
    Osteoporos Int. 2016;27:181-91.
    PubMed     Text format     Abstract available


  504. EASTELL R, Dijk DJ, Small M, Greenwood A, et al
    Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial.
    Osteoporos Int. 2016;27:309-18.
    PubMed     Text format     Abstract available


    December 2015
  505. AMICHE MA, Albaum JM, Tadrous M, Pechlivanoglou P, et al
    Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  506. POPP AW, Zysset PK, Lippuner K
    Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  507. CHEN JS, Hill CL, Lester S, Ruediger CD, et al
    Supplementation with omega-3 fish oil has no effect on bone mineral density in adults with knee osteoarthritis: a 2-year randomized controlled trial.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  508. COLOMA PM, de Ridder M, Bezemer I, Herings RM, et al
    Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  509. ANASTASILAKIS AD, Makras P
    Multiple clinical vertebral fractures following denosumab discontinuation.
    Osteoporos Int. 2015.
    PubMed     Text format    


  510. SILVERMAN SL, Adachi JD, Dennison E
    Bisphosphonate drug holidays: we reap what we sow.
    Osteoporos Int. 2015.
    PubMed     Text format    


  511. SVENSSON HK, Olofsson EH, Karlsson J, Hansson T, et al
    A painful, never ending story: older women's experiences of living with an osteoporotic vertebral compression fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  512. KLASSEN KM, Kimlin MG, Fairley CK, Emery S, et al
    Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  513. BETHEL M, Buzkova P, Fink HA, Robbins JA, et al
    Soluble CD14 and fracture risk.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  514. FREITAS PM, Garcia Rosa ML, Gomes AM, Wahrlich V, et al
    Central and peripheral fat body mass have a protective effect on osteopenia or osteoporosis in adults and elderly?
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  515. OIKONOMIDOU PR, Casu C, Yang Z, Crielaard B, et al
    Polycythemia is associated with bone loss and reduced osteoblast activity in mice.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  516. NAKAYAMA A, Major G, Holliday E, Attia J, et al
    Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  517. XU LH, Adams-Huet B, Poindexter JR, Maalouf NM, et al
    Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  518. MODI A, Sen S, Adachi JD, Adami S, et al
    Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results of the MUSIC-OS study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  519. BOURS S, de Vries F, van den Bergh JP, Lalmohamed A, et al
    Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  520. RUDANG R, Zoulakis M, Sundh D, Brisby H, et al
    Bone material strength is associated with areal BMD but not with prevalent fractures in older women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  521. PENONI DC, Torres SR, Farias ML, Fernandes TM, et al
    Association of osteoporosis and bone medication with the periodontal condition in elderly women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available



  522. IOF Regionals - 3rd Middle East & Africa Osteoporosis Meeting : Poster Presentation Abstracts.
    Osteoporos Int. 2015;26 Suppl 2:439-86.
    PubMed     Text format    



  523. IOF Regionals - 3rd Middle East & Africa Osteoporosis Meeting : Oral Communication Abstracts.
    Osteoporos Int. 2015;26 Suppl 2:427-37.
    PubMed     Text format    



  524. IOF Regionals - 3rd Middle East & Africa Osteoporosis Meeting : Plenary Lecture Abstracts.
    Osteoporos Int. 2015;26 Suppl 2:421-5.
    PubMed     Text format    


    November 2015
  525. ZHOU B, Huang Y, Li H, Sun W, et al
    Proton pump inhibitors and fracture risk: response to comments.
    Osteoporos Int. 2015.
    PubMed     Text format    


  526. KUIPERS AL, Miljkovic I, Evans R, Bunker CH, et al
    Optimal serum cholesterol concentrations are associated with accelerated bone loss in African ancestry men.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  527. SENAY A, Delisle J, Raynauld JP, Morin SN, et al
    Agreement between physicians' and nurses' clinical decisions for the management of the fracture liaison service (4iFLS): the Lucky Bone program.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  528. BROZEK W, Reichardt B, Zwerina J, Dimai HP, et al
    Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  529. MARCINIAK C, Gabet J, Lee J, Ma M, et al
    Osteoporosis in adults with cerebral palsy: feasibility of DXA screening and risk factors for low bone density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  530. MA C, Shuai B, Shen L, Yang YP, et al
    Serum carcinoembryonic antigen-related cell adhesion molecule 1 level in postmenopausal women: correlation with beta-catenin and bone mineral density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  531. AVILA ML, Pullenayegum E, Williams S, Shammas A, et al
    Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  532. MCCLOSKEY E
    A BMD threshold for treatment efficacy in osteoporosis? A need to consider the whole evidence base.
    Osteoporos Int. 2015.
    PubMed     Text format    


  533. UZOIGWE CE
    The real enemy is fragility fracture, not osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format    


  534. CLARK EM, Gooberman-Hill R, Peters TJ
    Using self-reports of pain and other variables to distinguish between older women with back pain due to vertebral fractures and those with back pain due to degenerative changes.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  535. LI Y, Zhou J, Wu Y, Lu T, et al
    Association of osteoporosis with genetic variants of circadian genes in Chinese geriatrics.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  536. KARJALAINEN JP, Riekkinen O, Toyras J, Jurvelin JS, et al
    New method for point-of-care osteoporosis screening and diagnostics.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  537. COSMAN F, Gilchrist N, McClung M, Foldes J, et al
    A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  538. CHEN F, Dai Z, Kang Y, Lv G, et al
    Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  539. FARSINEJAD-MARJ M, Saneei P, Esmaillzadeh A
    Dietary magnesium intake, bone mineral density and risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  540. MURRAY JC, Audet MC, Bedard M, Michou L, et al
    Bilateral distal fibula fractures in a woman on long-term bisphosphonate therapy.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  541. SUGIYAMA T, Torio T, Miyajima T, Kim YT, et al
    Calcium, proton pump inhibitors, and fracture risk.
    Osteoporos Int. 2015.
    PubMed     Text format    


  542. RUD B, Vestergaard A, Hyldstrup L
    Accuracy of densitometric vertebral fracture assessment when performed by DXA technicians-a cross-sectional, multiobserver study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  543. BEALL DP, Feldman RG, Gordon ML, Gruber BL, et al
    Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  544. SUMIDA K, Ubara Y, Hoshino J, Mise K, et al
    Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    October 2015
  545. JACOB L, Dreher M, Kostev K, Hadji P, et al
    Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  546. SATO H, Kondo N, Wada Y, Nakatsue T, et al
    The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  547. WEAVER CM, Alexander DD, Boushey CJ, Dawson-Hughes B, et al
    Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  548. DARUWALLA ZJ, Huq SS, Wong KL, Nee PY, et al
    Hip fractures, preceding distal radius fractures and screening for osteoporosis: should we be screening earlier? A minimum 10-year retrospective cohort study at a single centre.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  549. SANTI D, Madeo B, Carli F, Zona S, et al
    Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  550. AUBRY-ROZIER B, Gonzalez-Rodriguez E, Stoll D, Lamy O, et al
    Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  551. SELGA J, Nunez JH, Minguell J, Lalanza M, et al
    Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  552. HOLM JP, Amar AO, Hyldstrup L, Jensen JE, et al
    Hyponatremia, a risk factor for osteoporosis and fractures in women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  553. SUGIYAMA T, Kim YT, Oda H
    Both falling and bone fragility should be targeted to prevent hip fracture in older adults.
    Osteoporos Int. 2015.
    PubMed     Text format    


  554. EARLY C, Stuckey L, Tischer S
    Osteoporosis in the adult solid organ transplant population: underlying mechanisms and available treatment options.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  555. EBINA K, Noguchi T, Hirao M, Hashimoto J, et al
    Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  556. WEN Y, Guo X, Hao J, Xiao X, et al
    Integrative analysis of genome-wide association studies and gene expression profiles identified candidate genes for osteoporosis in Kashin-Beck disease patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  557. FINK HA, Litwack-Harrison S, Taylor BC, Bauer DC, et al
    Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  558. RAMCHAND SK, Chiang CY, Zebaze RM, Seeman E, et al
    Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  559. SOLOMON DH, Ruppert K, Zhao Z, Lian YJ, et al
    Bone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  560. WANG Q, Huang Q, Zeng Y, Liang JJ, et al
    Parity and osteoporotic fracture risk in postmenopausal women: a dose-response meta-analysis of prospective studies.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  561. EIKEN P, Vestergaard P
    Treatment of osteoporosis after alendronate or risedronate.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  562. DONNER DG, Elliott GE, Beck BR, Forwood MR, et al
    The effects of visceral obesity and androgens on bone: trenbolone protects against loss of femoral bone mineral density and structural strength in viscerally obese and testosterone-deficient male rats.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  563. HOLLOWAY KL, Henry MJ, Brennan-Olsen SL, Bucki-Smith G, et al
    Non-hip and non-vertebral fractures: the neglected fracture sites.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    September 2015
  564. GIFRE L, Vidal J, Carrasco JL, Muxi A, et al
    Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  565. HEGDE V, Jo JE, Andreopoulou P, Lane JM, et al
    Effect of osteoporosis medications on fracture healing.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  566. LEE SJ, Binkley N, Lubner MG, Bruce RJ, et al
    Opportunistic screening for osteoporosis using the sagittal reconstruction from routine abdominal CT for combined assessment of vertebral fractures and density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  567. LUO D, Ren H, Li T, Lian K, et al
    Rapamycin reduces severity of senile osteoporosis by activating osteocyte autophagy.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  568. ETHGEN O, Hiligsmann M, Burlet N, Reginster JY, et al
    Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  569. ALARCON T, Gonzalez-Montalvo JI, Martin-Vega A, Gotor P, et al
    Improving persistence and adherence to osteoporosis treatment: a challenge to solve.
    Osteoporos Int. 2015.
    PubMed     Text format    


  570. YAO W, Dai W, Jiang L, Lay EY, et al
    Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  571. ZHANG ZL, Liao EY, Xia WB, Lin H, et al
    Erratum to: Alendronate sodium/vitamin D combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension.
    Osteoporos Int. 2015.
    PubMed     Text format    


  572. HWANG IR, Choi YK, Lee WK, Kim JG, et al
    Association between prolonged breastfeeding and bone mineral density and osteoporosis in postmenopausal women: KNHANES 2010-2011.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  573. YUAN HF, Guo CA, Yan ZQ
    The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  574. LUO Y
    A biomechanical sorting of clinical risk factors affecting osteoporotic hip fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  575. BONE HG, Dempster DW, Eisman JA, Greenspan SL, et al
    Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial.
    Osteoporos Int. 2015.
    PubMed     Text format    


  576. JEMIELITA TO, Leonard MB, Baker J, Sayed S, et al
    Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  577. FRITZ J, Coster ME, Nilsson JA, Rosengren BE, et al
    The associations of physical activity with fracture risk-a 7-year prospective controlled intervention study in 3534 children.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  578. SHIN J, Sung J, Lee K, Song YM, et al
    Genetic influence on the association between bone mineral density and testosterone in Korean men.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  579. CARBONE S, Papalia M
    The amount of impaction and loss of reduction in osteoporotic proximal humeral fractures after surgical fixation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  580. JURIMAE J, Tillmann V, Cicchella A, Stefanelli C, et al
    Increased sclerostin and preadipocyte factor-1 levels in prepubertal rhythmic gymnasts: associations with bone mineral density, body composition, and adipocytokine values.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  581. KRISHNAMOORTHY D, Frechette DM, Adler BJ, Green DE, et al
    Marrow adipogenesis and bone loss that parallels estrogen deficiency is slowed by low-intensity mechanical signals.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    August 2015
  582. THORIN MH, Wihlborg A, Akesson K, Gerdhem P, et al
    Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  583. EDWARDS BJ, Gradishar WJ, Smith ME, Pacheco JA, et al
    Elevated incidence of fractures in women with invasive breast cancer.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  584. MOON RJ, Lim A, Farmer M, Segaran A, et al
    Validity of parental recall of children's fracture: implications for investigation of childhood osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  585. CLARK EM, Gould VC, Tobias JH, Horne R, et al
    Natural history, reasons for, and impact of low/non-adherence to medications for osteoporosis in a cohort of community-dwelling older women already established on medication: a 2-year follow-up study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  586. HOLZMUELLER CG, Karp S, Zeldow D, Lee DB, et al
    Development of a cloud-based application for the Fracture Liaison Service model of care.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  587. KARLSSON L, Lundkvist J, Psachoulia E, Intorcia M, et al
    Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  588. YONG JH, Masucci L, Hoch JS, Sujic R, et al
    Cost-effectiveness of a fracture liaison service-a real-world evaluation after 6 years of service provision.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  589. FECHTENBAUM J, Etcheto A, Kolta S, Feydy A, et al
    Sagittal balance of the spine in patients with osteoporotic vertebral fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  590. HU S, Liu CC, Chen G, Willett T, et al
    In vivo effects of two novel ALN-EP4a conjugate drugs on bone in the ovariectomized rat model for reversing postmenopausal bone loss.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  591. BARZILAY JI, Buzkova P, Kizer JR, Djousse L, et al
    Fibrosis markers, hip fracture risk, and bone density in older adults.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  592. SACHELARIE L, Farcas DM, Dartu L, Vasiliu M, et al
    Comparative study of diseases of the stomatognathic system and specific parameters of osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  593. DUMIC M, Putarek NR, Kusec V, Barisic N, et al
    Low bone mineral density for age/osteoporosis in triple A syndrome-an overlooked symptom of unexplained etiology.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  594. IWATA T, Ito H, Furu M, Hashimoto M, et al
    Periarticular osteoporosis of the forearm correlated with joint destruction and functional impairment in patients with rheumatoid arthritis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  595. MUSUMECI M, Palermo A, D'Onofrio L, Vadala G, et al
    Serum chitotriosidase in postmenopausal women with severe osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  596. HE H, Liu Y, Tian Q, Papasian CJ, et al
    Relationship of sarcopenia and body composition with osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  597. CHANG CY, Tang CH, Chen KC, Huang KC, et al
    The mortality and direct medical costs of osteoporotic fractures among postmenopausal women in Taiwan.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  598. LESLIE WD, Brennan-Olsen SL, Morin SN, Lix LM, et al
    Fracture prediction from repeat BMD measurements in clinical practice.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    July 2015
  599. YAN Z, Huang H, Li J, Wang J, et al
    Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  600. LIU Z, Weaver J, de Papp A, Li Z, et al
    Disparities in osteoporosis treatments.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  601. HA KY, Park KS, Kim SI, Kim YH, et al
    Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing?
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  602. PAPAPOULOS S, Lippuner K, Roux C, Lin CJ, et al
    The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  603. GILLETTE C, Howerton DM, Williams BD, Mahmood MA, et al
    Medication persistence in older women with osteoporosis: a pilot study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  604. ZHUKOUSKAYA VV, Eller-Vainicher C, Gaudio A, Privitera F, et al
    Erratum to: The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients.
    Osteoporos Int. 2015.
    PubMed     Text format    


  605. LING Y, Gao X, Lin H, Ma H, et al
    A common polymorphism rs1800247 in osteocalcin gene was associated with serum osteocalcin levels, bone mineral density, and fracture: the Shanghai Changfeng Study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  606. SILVERMAN SL, Wang A, Cheng L, Yang Y, et al
    Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  607. NOORAFSHAN A, Dabbaghmanesh MH, Tanideh N, Koohpeyma F, et al
    Stereological study of the effect of black olive hydroalcoholic extract on osteoporosis in vertebra and tibia in ovariectomized rats.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  608. PICKHARDT PJ, Lauder T, Pooler BD, Munoz Del Rio A, et al
    Effect of IV contrast on lumbar trabecular attenuation at routine abdominal CT: correlation with DXA and implications for opportunistic osteoporosis screening.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  609. ALBAUM JM, Levesque LE, Gershon AS, Liu G, et al
    Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996-2012.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  610. ZHUKOUSKAYA VV, Vainicher CE, Gaudio A, Privitera F, et al
    The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  611. COMPSTON J
    Overdiagnosis of osteoporosis: fact or fallacy?
    Osteoporos Int. 2015.
    PubMed     Text format    


  612. LIU W, Wang T, Yang C, Darvell BW, et al
    Alkaline biodegradable implants for osteoporotic bone defects-importance of microenvironment pH.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  613. OLMOS JM, Hernandez JL, Garcia-Velasco P, Martinez J, et al
    Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  614. WANG CY, Fu SH, Wang CL, Chen PJ, et al
    Serotonergic antidepressant use and the risk of fracture: a population-based nested case-control study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    June 2015
  615. AMOUZOUGAN A, Deygat A, Trombert B, Constant E, et al
    Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  616. TIAN FM, Yang K, Wang WY, Luo Y, et al
    Calcitonin suppresses intervertebral disk degeneration and preserves lumbar vertebral bone mineral density and bone strength in ovariectomized rats.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  617. YOSHIGA D, Sasaguri M, Matsuo K, Kokuryou S, et al
    Erratum to: Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.
    Osteoporos Int. 2015.
    PubMed     Text format    


  618. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Erratum to: Analysis of daily teriparatide treatment for osteoporosis in men.
    Osteoporos Int. 2015.
    PubMed     Text format    


  619. HARVEY NC, Kanis JA, Oden A, Burge RT, et al
    FRAX and the effect of teriparatide on vertebral and non-vertebral fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  620. HERNANDEZ I, Pinera A
    Incidence of fracture events with teriparatide: role of study design.
    Osteoporos Int. 2015.
    PubMed     Text format    


  621. HARVEY NC, Kanis JA, Oden A, Nakamura T, et al
    Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  622. D'AMELIO P, Sassi F, Buondonno I, Fornelli G, et al
    Treatment with intermittent PTH increases Wnt10b production by T cells in osteoporotic patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  623. FERRARI S, Adachi JD, Lippuner K, Zapalowski C, et al
    Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  624. ZHANG C, Ma J, Chen G, Fu D, et al
    Evaluation of common variants in CNR2 gene for bone mineral density and osteoporosis susceptibility in postmenopausal women of Han Chinese.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  625. BRIOT K, Fechtenbaum J, Etcheto A, Kolta S, et al
    Diagnosis of vertebral fractures using a low-dose biplanar imaging system.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  626. GUO Z, Yang J, Zheng Y, Wang Y, et al
    Thoracolumbar fascia injury associated with residual back pain after percutaneous vertebroplasty: a compelling study.
    Osteoporos Int. 2015.
    PubMed     Text format    


  627. NARANJO A, Ojeda-Bruno S, Bilbao-Cantarero A, Quevedo-Abeledo JC, et al
    Two-year adherence to treatment and associated factors in a fracture liaison service in Spain.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  628. YAN Y, Zou T, Xu R
    Reply to "Thoracolumbar fascia injury associated with residual back pain after percutaneous vertebroplasty: a compelling study".
    Osteoporos Int. 2015.
    PubMed     Text format    


  629. YOSHIGA D, Sasaguri M, Matsuo K, Kokuryou S, et al
    Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    May 2015
  630. HADJI P, Papaioannou N, Gielen E, Feudjo Tepie M, et al
    Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  631. NAKAMURA T, Ito M, Hashimoto J, Shinomiya K, et al
    Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  632. CROCKETT K, Arnold CM, Farthing JP, Chilibeck PD, et al
    Bone strength and muscle properties in postmenopausal women with and without a recent distal radius fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  633. SANGTARASH F, Manshadi FD, Sadeghi A
    The relationship of thoracic kyphosis to gait performance and quality of life in women with osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  634. MATUTE-LLORENTE A, Gonzalez-Aguero A, Gomez-Cabello A, Olmedillas H, et al
    Effect of whole body vibration training on bone mineral density and bone quality in adolescents with Down syndrome: a randomized controlled trial.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  635. NAYLOR KE, Jacques RM, Paggiosi M, Gossiel F, et al
    Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  636. WU CT, Yang YH, Chen PC, Chen MF, et al
    Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  637. TIAN Y, Shen L, Wu J, Xu G, et al
    Sleep duration and timing in relation to osteoporosis in an elderly Chinese population: a cross-sectional analysis in the Dongfeng-Tongji cohort study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  638. MARQUES A, Lourenco O, da Silva JA
    The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  639. COSMAN F, de Beur SJ, LeBoff MS, Lewiecki EM, et al
    Erratum to: Clinician's guide to prevention and treatment of osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format    


  640. TSUKUTANI Y, Hagino H, Ito Y, Nagashima H, et al
    Epidemiology of fragility fractures in Sakaiminato, Japan: incidence, secular trends, and prognosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  641. WANG O, Hu Y, Gong S, Xue Q, et al
    A survey of outcomes and management of patients post fragility fractures in China.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  642. KEMMLER W, Bebenek M, Kohl M, von Stengel S, et al
    Exercise and fractures in postmenopausal women. Final results of the controlled Erlangen Fitness and Osteoporosis Prevention Study (EFOPS).
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  643. MIYAKOSHI N, Hongo M, Kobayashi T, Abe T, et al
    Improvement of spinal alignment and quality of life after corrective surgery for spinal kyphosis in patients with osteoporosis: a comparative study with non-operated patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  644. KLOP C, Gibson-Smith D, Elders PJ, Welsing PM, et al
    Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  645. XIN M, Yang Y, Zhang D, Wang J, et al
    Attenuation of hind-limb suspension-induced bone loss by curcumin is associated with reduced oxidative stress and increased vitamin D receptor expression.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  646. FERLIN A, Selice R, Di Mambro A, Ghezzi M, et al
    Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  647. YOUN JC, Lee SJ, Lee HS, Oh J, et al
    Exercise capacity independently predicts bone mineral density and proximal femoral geometry in patients with acute decompensated heart failure.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  648. HOOVER KB, Miller CG, Galante NC, Langman CB, et al
    A double-blind, randomized, Phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  649. CIZMIC AD, Heilmann RM, Milchak JL, Riggs CS, et al
    Impact of interactive voice response technology on primary adherence to bisphosphonate therapy: a randomized controlled trial.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  650. SCILLITANI A, Mazziotti G, Di Somma C, Moretti S, et al
    Cortisol and the muscle-bone axis: response to comments by Molfino et al.
    Osteoporos Int. 2015;26:1661-2.
    PubMed     Text format    


  651. BURDEN AM, Tadrous M, Calzavara A, Cadarette SM, et al
    Uptake and characteristics of zoledronic acid and denosumab patients and physicians in Ontario, Canada: impact of drug formulary access.
    Osteoporos Int. 2015;26:1525-33.
    PubMed     Text format     Abstract available


  652. BINKLEY N, Lappe J, Singh RJ, Khosla S, et al
    Can vitamin D metabolite measurements facilitate a "treat-to-target" paradigm to guide vitamin D supplementation?
    Osteoporos Int. 2015;26:1655-60.
    PubMed     Text format     Abstract available


    April 2015
  653. KREGE JH, Burge RT, Marin F
    Teriparatide fracture effectiveness in the real world.
    Osteoporos Int. 2015.
    PubMed     Text format    


  654. AHMED LA, Shigdel R, Joakimsen RM, Eldevik OP, et al
    Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  655. VAN DEN BERG P, Schweitzer DH, van Haard PM, van den Bergh JP, et al
    Meeting international standards of secondary fracture prevention: a survey on Fracture Liaison Services in the Netherlands.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  656. WIHLBORG A, Englund M, Akesson K, Gerdhem P, et al
    Fracture predictive ability of physical performance tests and history of falls in elderly women: a 10-year prospective study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  657. EBINA K, Hashimoto J, Shi K, Kashii M, et al
    Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in RA patients: response to Mokuda.
    Osteoporos Int. 2015;26:1445.
    PubMed     Text format    


  658. MOKUDA S
    Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in rheumatoid arthritis patients.
    Osteoporos Int. 2015;26:1443.
    PubMed     Text format    


  659. MURAI IH, Roschel H, Pabis LV, Takayama L, et al
    Exercise training, creatine supplementation, and bone health in ovariectomized rats.
    Osteoporos Int. 2015;26:1395-404.
    PubMed     Text format     Abstract available


  660. CESAREO R, Di Stasio E, Vescini F, Campagna G, et al
    Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
    Osteoporos Int. 2015;26:1295-302.
    PubMed     Text format     Abstract available


    March 2015
  661. ITO K, Leslie WD
    Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  662. BABA T, Hagino H, Nonomiya H, Ikuta T, et al
    Inadequate management for secondary fracture prevention in patients with distal radius fracture by trauma surgeons.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  663. DAMJI AN, Bies K, Alibhai SM, Jones JM, et al
    Bone health management in men undergoing ADT: examining enablers and barriers to care.
    Osteoporos Int. 2015;26:951-9.
    PubMed     Text format     Abstract available


  664. BORON D, Kaminski A, Kotrych D, Bogacz A, et al
    Polymorphism of vitamin D3 receptor and its relation to mineral bone density in perimenopausal women.
    Osteoporos Int. 2015;26:1045-52.
    PubMed     Text format     Abstract available


  665. KRAUSE M, Keller J, Beil B, van Driel I, et al
    Calcium gluconate supplementation is effective to balance calcium homeostasis in patients with gastrectomy.
    Osteoporos Int. 2015;26:987-95.
    PubMed     Text format     Abstract available


    February 2015
  666. MCCLOSKEY EV, Kanis JA, Oden A, Harvey NC, et al
    Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  667. RASCH LA, van Tuyl LH, de van der Schueren MA, Bultink IE, et al
    Estimation of dietary calcium intake.
    Osteoporos Int. 2015;26:835-6.
    PubMed     Text format    


  668. MACDONALD HM, Black AJ
    Validation of a short questionnaire for estimating dietary calcium intakes.
    Osteoporos Int. 2015;26:837.
    PubMed     Text format    


  669. LAI CC, Chen WS, Chang DM, Tsao YP, et al
    Increased serum fibroblast growth factor-23 and decreased bone turnover in patients with systemic lupus erythematosus under treatment with cyclosporine and steroid but not steroid only.
    Osteoporos Int. 2015;26:601-10.
    PubMed     Text format     Abstract available


    January 2015
  670. LOOKER AC
    Dysmobility syndrome and mortality risk in US men and women age 50 years and older.
    Osteoporos Int. 2015;26:93-102.
    PubMed     Text format     Abstract available


  671. KALLURU R, Ames R, Mason B, Bolland MJ, et al
    Bone density in healthy men after cessation of calcium supplements: 20-month follow-up of a randomized controlled trial.
    Osteoporos Int. 2015;26:173-8.
    PubMed     Text format     Abstract available


  672. YOSHIMURA N, Muraki S, Oka H, Nakamura K, et al
    Serum levels of 25-hydroxyvitamin D and the occurrence of musculoskeletal diseases: a 3-year follow-up to the road study.
    Osteoporos Int. 2015;26:151-61.
    PubMed     Text format     Abstract available


  673. RIZZOLI R, Sigaud A, Azria M, Herrmann FR, et al
    Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal women.
    Osteoporos Int. 2015;26:383-93.
    PubMed     Text format     Abstract available


  674. STUCKEY BG, Sallie R
    Alendronate-induced unmasking or deterioration of coeliac disease: a case series.
    Osteoporos Int. 2015;26:411-4.
    PubMed     Text format    


  675. SILVERMAN S, Curtis J, Saag K, Flahive J, et al
    International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study.
    Osteoporos Int. 2015;26:419-20.
    PubMed     Text format    


  676. CHATTERJEE M, Hatori K, Duyck J, Sasaki K, et al
    High-frequency loading positively impacts titanium implant osseointegration in impaired bone.
    Osteoporos Int. 2015;26:281-90.
    PubMed     Text format     Abstract available


  677. ZHU TY, Griffith JF, Qin L, Hung VW, et al
    Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors.
    Osteoporos Int. 2015;26:261-72.
    PubMed     Text format     Abstract available


    October 2014
  678. ROBINSON PJ, Bell RJ, Zecena Morales CS, Fradkin P, et al
    Minimal-trauma fracture in women with breast cancer surviving for at least 5 years from diagnosis.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    September 2014
  679. MOLFINO A, Aversa Z, Muscaritoli M
    Cortisol and the muscle-bone axis.
    Osteoporos Int. 2014;25:2331-2.
    PubMed     Text format    


    August 2014
  680. SALE JE, Bogoch E, Hawker G, Gignac M, et al
    Patient perceptions of provider barriers to post-fracture secondary prevention.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    July 2014
  681. NELSON SD, Nelson RE, Cannon GW, Lawrence P, et al
    Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  682. GIBSON-SMITH D, Klop C, Elders PJ, Welsing PM, et al
    The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  683. OMSLAND TK, Magnus JH
    Forecasting the burden of future postmenopausal hip fractures.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    June 2014
  684. DREW S, Sheard S, Chana J, Cooper C, et al
    Describing variation in the delivery of secondary fracture prevention after hip fracture: an overview of 11 hospitals within one regional area in England.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    May 2014
  685. HANSEN KE, Blank RD, Palermo L, Fink HA, et al
    What analytic method should clinicians use to derive spine T-scores and predict incident fractures in men? Results from the MrOS study.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    March 2014
  686. CANO A, Mendoza N, Sanchez-Borrego R
    Sequential use of antiresorptives in younger women.
    Osteoporos Int. 2014;25:1191-2.
    PubMed     Text format    


    February 2014
  687. DONNEAU AF, Reginster JY
    Cardiovascular safety of strontium ranelate: real-life assessment in clinical practice.
    Osteoporos Int. 2014;25:397-8.
    PubMed     Text format    


  688. ABRAHAMSEN B, Grove EL, Vestergaard P
    Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate.
    Osteoporos Int. 2014;25:757-62.
    PubMed     Text format     Abstract available


  689. SCILLITANI A, Mazziotti G, Di Somma C, Moretti S, et al
    Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?
    Osteoporos Int. 2014;25:441-6.
    PubMed     Text format     Abstract available


  690. HAGE MP, El-Hajj Fuleihan G
    Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass.
    Osteoporos Int. 2014;25:423-39.
    PubMed     Text format     Abstract available


  691. MATEOS F, Valero C, Olmos JM, Casanueva B, et al
    Bone mass and vitamin D levels in women with a diagnosis of fibromyalgia.
    Osteoporos Int. 2014;25:525-33.
    PubMed     Text format     Abstract available


  692. MACINTYRE NJ, Lorbergs AL, Adachi JD
    Inclinometer-based measures of standing posture in older adults with low bone mass are reliable and associated with self-reported, but not performance-based, physical function.
    Osteoporos Int. 2014;25:721-8.
    PubMed     Text format     Abstract available


  693. PHAN V, Blydt-Hansen T, Feber J, Alos N, et al
    Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.
    Osteoporos Int. 2014;25:627-37.
    PubMed     Text format     Abstract available


  694. BANG UC, Hyldstrup L, Jensen JE
    The impact of recombinant parathyroid hormone on malignancies and mortality: 7 years of experience based on nationwide Danish registers.
    Osteoporos Int. 2014;25:639-44.
    PubMed     Text format     Abstract available


  695. LAZARUS S, Zankl A, Duncan EL
    Next-generation sequencing: a frameshift in skeletal dysplasia gene discovery.
    Osteoporos Int. 2014;25:407-22.
    PubMed     Text format     Abstract available


  696. SHIN D, Kim S, Kim KH, Park SM, et al
    Importance of fat mass and lean mass on bone health in men: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV).
    Osteoporos Int. 2014;25:467-74.
    PubMed     Text format     Abstract available


    December 2013
  697. ITO M, Oishi R, Fukunaga M, Sone T, et al
    The effects of once-weekly teriparatide on hip structure and biomechanical properties assessed by CT.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


    November 2013
  698. RAJAPAKSE CS , Phillips EA, Sun W, Wald MJ, et al
    Vertebral deformities and fractures are associated with MRI and pQCT measures obtained at the distal tibia and radius of postmenopausal women.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


    October 2013
  699. BOTTAI V , Giannotti S, Dell'osso G, De Paola G, et al
    Atypical femoral fractures: retrospective radiological study of 319 femoral fractures and presentation of clinical cases.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


    September 2013
  700. EEKMAN DA , van Helden SH, Huisman AM, Verhaar HJ, et al
    Optimizing fracture prevention: the fracture liaison service, an observational study.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


    July 2013
  701. ACU K , Scheel M, Issever AS
    Time dependency of bone density estimation from computed tomography with intravenous contrast agent administration.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: